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Abstract
Quality of life studies in Duchenne Muscular Dystrophy are scarce. This study explores the
relationship between the broad concept of quality of life and the more focused concept of
health-related quality of life and examines the relationships between patient and family
characteristics and health-related quality of life. Participants were recruited from the
Canadian Neuromuscular Disease Registry, 98 parents and 85 children completed the Quality
of My Life and Pediatric Quality of Life Inventory questionnaires. Simple regression was
used to examine the relationship between quality of life and health-related quality of life.
Multivariable linear regressions were used to determine child and family characteristics
associated with health-related quality of life outcomes. Higher levels of subjective fatigue
and use of wheelchair emerged as factors most consistently associated with lower levels
health-related quality of life. Interventions to reduce fatigue could lead to improvement of
health-related quality of life for children with Duchenne Muscular Dystrophy.
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Chapter 1
1

Introduction and Research Objectives

1.1 Overview of thesis
Duchenne Muscular Dystrophy (DMD) is a progressive, chronic neuromuscular disorder,
affecting 1 in 5,000 boys. It is characterized by gradual loss of muscle strength resulting
in profound physical disability and premature death. Due to the life-limiting and chronic
nature of this disease, maximizing quality of life in these children is of the utmost
importance. This thesis aims to provide a comprehensive description of quality of life and
health-related quality of life in children with DMD from the children’s and parents’
perspectives. Furthermore, the relationship between the broader concept of quality of life
and the narrower concept of health-related quality of life is investigated. Finally, this
thesis explores the clinical and demographic factors associated with quality of life and
health-related quality of life in children with DMD.

1.2 Background
1.2.1

Quality of life and health-related quality of life in children with
chronic illnesses

Advances in medicine have expanded the focus of healthcare from extending life to also
include improving quality of life. The World Health Organization Quality of Life group
has defined quality of life as an ‘individual’s perception of their position in life, in the
context of culture and value systems in which they live and in relation to their goals,
expectations, standards, and concerns’ (“The World Health Organization quality of life
assessment (WHOQOL),” 1995). Health-related quality of life (HRQOL) narrows the
scope of quality of life (QOL) and focuses specifically on the impact of illness and
treatments on a person’s life (De Civita et al., 2005; Guyatt et al., 1993; Spieth & Harris,
1996). HRQOL does not pertain to aspects of life such as environmental quality and
political stability (Guyatt et al., 1993; Taylor et al., 2008), which are important, but
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cannot be influenced by healthcare intervention. The primary focus of this thesis is on
HRQOL, with one component aimed at distinguishing and exploring the relationship
between QOL and HRQOL. Although there has not been a complete consensus on the
operational definition of HRQOL, two recurrent characteristics that underlie most
measurements of HRQOL have emerged: they are subjective and multidimensional
(Matza et al., 2004). Subjectivity refers to the fact that HRQOL measures patient’s own
perception of their health or life, in contrast with objective clinical measures such as
blood pressure; multidimensionality refers to measurement of HRQOL from multiple
aspects of a person’s life, for example, the physical, psychological and social aspects.

Rationale for studying HRQOL in children with chronic illnesses
As survival rates and life expectancy for many childhood illnesses increase, improvement
in quality of life for these children becomes increasingly important. The rationale for
studying HRQOL in children with chronic illnesses is manifold. First, HRQOL is an
important component of outcome assessment and provides information not captured by
traditional clinical measures. More often, patient-reported outcomes such as HRQOL are
being recognized as important end-points of clinical trials in conjunction with traditional
clinical measures (Drotar, 2004; Eiser & Morse, 2001a). Apart from clinical trials,
HRQOL measures may also be used to evaluate the success of interventions and services
in clinical settings (Eiser & Morse, 2001a). Second, while traditional medical care tends
to rely on physiological measurements such as blood pressure, there are evidence that
these measures are not always of the most importance to patients (Guyatt et al., 1993;
Ronen et al., 2011). Furthermore, physiological measures do not necessarily correlate
well with subjective well-being. Two patients who exhibit the same physical symptoms
may have very different subjective experiences (Eiser & Morse, 2001a; Guyatt et al.,
1993).Thus, management of physical symptoms is no longer sufficient in the treatment of
a chronic illness. HRQOL studies allow researchers and clinicians to elucidate the
determinants of HRQOL, identify risk factors for poor HRQOL, and ultimately improve
HRQOL, which some have argued is the ultimate goal of managing chronic illnesses
(Eiser & Morse, 2001b; Payot & Barrington, 2011).
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Considerations in assessing QOL and HRQOL in children
There are a number of conceptual and methodological considerations when studying
childhood QOL and HRQOL. Three of these considerations: the distinction between
quality of life and health-related quality of life; the existence of generic and diseasespecific measures, and the existence of child and parent reports, are discussed below.
Quality of life and health-related quality of life
Quality of life and health-related quality of life are terms that are often used
interchangeably, but in fact represent different concepts. A systematic review of
paediatric QOL and HRQOL measures (Davis et al., 2006) identified eleven different
definitions of QOL and HRQOL across fourteen generic and 25 disease specific
measures. Although it is recognized that there should be distinction between QOL and
HRQOL, few studies have empirically differentiated these two concepts (Davis et al.,
2006; De Civita et al., 2005; Eiser & Morse, 2001a; Gill & Feinstein, 1994; Guyatt et al.,
1993; Ronen et al., 2011). It has been suggested that two global ratings, one for overall
QOL, and one for HRQOL be used (Gill & Feinstein, 1994). Despite these
recommendations, to our knowledge, there is only one example in paediatric patients
where the distinction between QOL and HRQOL has been examined. Feldman et al.
(2000) designed the Quality of My Life (QoML) questionnaire to ask children and their
parents to rate the child’s ‘overall’ quality of life (QOL) and their quality of life
‘considering my health’ (HRQOL) and found that both children and their parents
differentiated between these two constructs, and that HRQOL only explained 30% of the
variability in QOL. This was done in a sample of children being treated for rheumatoid
arthritis. Thus, there exist empirical support for the distinction between QOL and
HRQOL.
Another reason for examining the relationship between QOL and HRQOL is the notion
of ‘disability paradox’, which is the phenomenon whereby people with disabilities report
good or excellent QOL, when external observers might assume they have quite poor QOL
(Albrecht & Devlieger, 1999). As part of the development of the QoML measure,
Feldman et al. (2000) conducted qualitative debriefing with children and parents, many

4

of whom reported that health contributed only in small part to overall QOL. People may
attach different weights to the various aspects they deem to contribute to their QOL.
Therefore it is possible for someone to have good or excellent QOL despite poorer
HRQOL and it is reasonable to assume that the relationship between the two may change
at different stages of disease progression. Determining the factors that contribute to QOL
beyond HRQOL is especially important to patients with DMD, where physical
deterioration is inevitable but a good QOL may be achievable.
Generic and disease-specific measures
HRQOL measures can be divided into generic and disease-specific. Generic measures are
applicable across different disease populations and thus are often used to compare of
HRQOL in groups with various diseases and to those in the general population. Diseasespecific questionnaires include items that are pertinent to a particular condition.
Compared to generic measures, disease-specific measures have greater sensitivity and
specificity, and are better at detecting treatment effects and changes across time (Eiser &
Morse, 2001a; Quittner et al., 2003; Spieth & Harris, 1996), however, they do not allow
for comparison to other disease groups or to a general population. Therefore, it has been
recommended that both disease–specific and generic measures be used in a
complementary fashion (Spieth & Harris, 1996).
Child self-reports and parent proxy-reports
Assessing QOL and HRQOL in children has its unique challenges. Children were once
considered incapable of reliably reporting their own QOL or HRQOL out of concerns
they were not cognitively able to understand measures of QOL or HRQOL, and parentproxy measures were used instead (Eiser & Morse, 2001c; Quittner et al., 2003).
However, it has since been recognized that children, like adults, are the best informants
on their own subjective experiences and should report their own QOL and HRQOL
whenever possible. There are evidence supporting the reliability and validity of children’s
report of their health state (Drotar, 2004). Children as young as five have been found able
to reliably report their HRQOL (Varni et al., 2007a). Furthermore, parents may not
always be able to accurately interpret their children’s emotional state or be able to
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directly observe their social interactions (Quittner et al., 2003). On the other hand, in
situations where the child is too young, sick or cognitively impaired to report their QOL
and HRQOL, parent-proxy measures need to be used. In addition, parent reports are still
important because of parents’ influence on healthcare decisions for their children
(Palermo et al., 2008). Both child and parent perspectives offer unique information and
thus it has been recommended that QOL and HRQOL be collected from multiple
informants (Drotar, 2004; Eiser & Morse, 2001d; Palermo et al., 2008).

1.2.2

Duchenne Muscular Dystrophy

Genetics and pathology
Duchenne Muscular Dystrophy (DMD) is the most common and severe form of
childhood muscular dystrophy. It is the result of mutations in the dystrophin gene, located
on the X-chromosome (Hoffman et al., 1988). Due to the X-linked mode of inheritance,
almost all affected individuals are male. The incidence for DMD is estimated to be in the
range of 1 in 3600-6000 live-born male infants (Emery, 1991). A retrospective study
carried out in Nova Scotia found that the incidence of DMD has remained stable between
the years of 1969 and 2008 (Dooley et al., 2010).
Dystrophin proteins are thought to play a structural role in muscle cell membrane,
maintaining its integrity. Absence of dystrophin results in muscle cells being more prone
to damage from mechanical stress (Deconinck & Dan, 2007; McDonald et al., 1995). In
DMD patients, skeletal muscles are affected at birth, but most boys do not show
symptoms of the disease until they are between 3 to 5 years of age. With increasing
availability and efficiency of molecular technology, genetic testing has become the gold
standard diagnostic tool (Bushby et al., 2010a).

Clinical features
Progressive muscle weakness
Proximal, lower extremity muscles are the first to show signs of degeneration. As muscle
deterioration progresses, the boys lose ambulation. Age of loss ambulation has
historically been between the ages of 7 to 12 (Biggar, 2006; Brooke et al., 1989). Loss of
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ambulation happens rapidly, over the span of a few weeks to a few months. By mid-teens,
almost all boys are in wheelchairs. As the disease progresses, the affected individual
becomes gradually weaker in the upper limbs, eventually losing the ability to perform
daily activities. It has been thought that there are two ‘plateaus’ in the progression of
DMD: the period between diagnosis and loss of ambulation and the period from loss of
ambulation to significant cardio and respiratory compromises. During these plateau
phases, the health of the child with DMD can remain relatively stable.
Throughout the progression of DMD, initial diagnosis and loss of ambulation are perhaps
the two most life-altering events faced by the affected child and his family. Parents report
that they are overwhelmed and devastated by the diagnosis of DMD in their child (Green
& Murton, 1996), often more so than the children themselves. Parents have also reported
experiencing increased stress and emotional upheaval around the time their son loses
ambulation (Bothwell et al., 2002; Bray et al., 2011; Erby et al., 2006). However, as with
any other major stress, families adjust to it (McCubbin & McCubbin, 1993). The periods
immediately after diagnosis and after loss of ambulation may be particularly vulnerable
times for the child and his family and warrant closer scrutiny.
Orthopedic complications
One of the most concerning complications related to DMD is the development of
scoliosis. Various studies have reported that between 74% and 100% of DMD subjects
develop scoliosis (Muntoni et al., 2006). In addition to causing discomfort, scoliosis
further impedes respiratory function, which is already compromised in DMD patients.
Bone fractures are common, occurring in 21% to 44% of boys (Kornberg & Yiu, 2008).
Some patients have lost mobility permanently due to bone fractures (McDonald et al.,
2002). Taken together, these complications indicate bone health of boys with DMD is
compromised, and may have serious impact on their quality of life.
Pulmonary function decline
Boys with DMD begin to experience respiratory problems between the ages of 9 and 11
years due to loss of respiratory muscle strength. Respiratory insufficiency first manifests
during sleep, boys with DMD may experience sleep apnea, decreased quality of sleep or
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frequent wakening throughout the night (Polat et al., 2012). Along with muscular
deterioration, vital capacity further decreases. Eventually, all boys require assisted
ventilation, usually in the form of nocturnal bilevel positive airway pressure (BiPAP) to
support their breathing (Biggar, 2006).
Cardiomyopathy
Cardiac muscles are affected in DMD patients. Cardiomyopathies may often be
subclinical in younger boys due to the boys’ lack of strenuous activities and thus low
demand placed on the heart. However, as cardiac muscles weakens further, the likelihood
of symptomatic cardiomyopathies increases. One study reports that clinically apparent
cardiac problems are present in one-third of DMD patients by 14 years of age, and
present in all patients over 18 years of age (Nigro et al., 1990).
Cognitive delay and psychological functioning
The prevalence of intellectual disability in the Duchenne population is higher in the
general population. Dystrophin is expressed in the central nervous system in a number of
different isoforms, regulated by different promoters (Mehler, 2000). There is evidence
that mutations in specific regulatory regions in these brain isoforms are linked with
mental retardation (Bardoni et al., 2000). There is also evidence of increased likelihood
of being diagnosed with a developmental disorder such as attention deficit hyperactivity
disorder or autism (Hendriksen & Vles, 2008). While boys with DMD are more likely to
exhibit cognitive and psychosocial deficits, there is still great variability within this
population. The extent of heterogeneity in intellectual and psychological deficits is
greater than in motor deficits in boys with DMD.
Survival
The most common cause of death for Duchenne patients is respiratory failure, followed
by heart failure (Finsterer, 2006). As with many other diseases, improvement in medical
technology and quality of care has increased survival in DMD patients. The mean life
expectancy has increased from 14 years of age in the 1960s to 25 years of age in the
1990s (Eagle et al., 2002; Passamano et al., 2012).
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Treatment and Care
Glucocorticoids
There is no cure for Duchenne muscular dystrophy. The most commonly prescribed
medications are glucocorticoids, which have become the standard of practice in treating
DMD. Long term cohort studies have shown that glucocorticoids can prolong ambulation
for up to five years (Moxley et al., 2010). While glucocorticoids have obvious benefits,
they also have serious side-effects. one of the most common side-effects is weight gain,
and it can lead adverse health consequences such as increased incidence of sleep apnea
and increased burden on the respiratory system (McMillan et al., 2010). Other adverse
effects include increase risk of fracture, growth retardation, delayed puberty, behavioral
changes, and immune suppression (Ay et al., 2009; Bushby et al., 2010a; Moxley et al.,
2010).
Multidisciplinary care
Due to the multi-systemic nature of the disease, it has been recommended that children
with DMD be followed up in multidisciplinary clinics where comprehensive care can be
provided by a variety of specialists (Bushby et al., 2010b). In Canada, paediatric
neuromuscular clinics exist across the country and care teams are composed of
neurologists, respirologists, physical therapists and other health care professionals
(McMillan et al., 2010). Patients visit clinics every 6 to 12 months, and in addition to
receiving management of muscle deterioration, are monitored routinely for orthopedic,
respiratory and cardiac abnormalities so that complications can be managed as they arise.
DMD patients experience gradual loss of respiratory muscle, resulting in hypoventilation,
particularly during sleep. Non-invasive positive pressure assisted ventilation is normally
the first step in providing respiratory support to DMD patients (McMillan et al., 2010).
Cardiac function is monitored regularly via electrocardiogram and echocardiogram.
Dilated cardiomyopathies are treated with angiotensin converting enzyme inhibitors and
beta-blockers (Bushby et al., 2010b; Finsterer, 2006).
While pharmaceutical and technological interventions have improved quantity and
quality of life for Duchenne patients over the past few decades, the disease remains a
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relentlessly progressive one that is devastating for the affected child and his family. In the
past decade, with the advancement of molecular techniques, many therapies that show
promise in the treatment of DMD have emerged. As more of these therapies undergo
clinical trials, proper assessment of trial outcomes is crucial.

1.3 Objectives
The literature assessing QOL and HRQOL in children with DMD is scarce. The available
studies have several limitations that will be discussed in more detail in the next chapter.
Briefly, many of these studies have small sample sizes, uses only parent-reported
HRQOL and draw samples from a single clinic. Furthermore, almost all studies are
descriptive, and do not examine potential determinants of HRQOL.
There is a need for a more comprehensive examination of QOL and HRQOL in children
with DMD from both children’s and parents’ perspectives, using general and diseasespecific measures. Examining the relationship between QOL and HRQOL will allow us
to gain a better understanding of the role health plays in overall QOL. Exploring factors
that are associated with HRQOL would allow us to identify potential determinants of
HRQOL that could contribute to improvement of HRQOL. With these gaps of knowledge
in mind, the objectives of this thesis are:

1. Describe the QOL and HRQOL in a sample of boys with DMD in Canada from both
children’s and parents’ perspectives.
2. Examine the relationship between QOL and HRQOL.
Hypothesis: QOL and HRQOL will be rated as distinct but related concepts by boys
with DMD and their parents.
3. Explore child and family characteristics that contribute to any difference between
QOL and HRQOL.
Hypothesis: Family characteristics relating to social economic status will be
associated with the difference between QOL and HRQOL.
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4. Explore associations of child and family characteristics with multidimensional
measures of HRQOL.
Hypothesis: Age and ambulation status will be associated with the physical
component and the total component of a multidimensional measure of HRQOL;
family stress will be significantly associated with the psychosocial component of
multidimensional HRQOL.
5. Compare QOL and HRQOL of ambulant boys who were diagnosed recently to those
who were diagnosed longer ago.
Hypothesis: For boys who are still ambulant, those who have been diagnosed before
2012 will have better QOL and HRQOL than those who have been diagnosed after
2012.
6. Compare QOL and HRQOL of boys who have lost ambulation recently to those who
lost ambulation longer ago.
Hypothesis: For boys who are non-ambulant, those who lost ambulation before 2012
will have better QOL and HRQOL than those who lost ambulation after 2012.

11

Chapter 2
2

Literature Review

2.1 Methodology of Literature Review
A literature search was conducted in January 2014 in the electronic databases MEDLINE,
EMBASE and PsychINFO. Using the following key words: 1) Duchenne Muscular
Dystrophy; 2) quality of life OR health related quality of life OR health-related quality of
life OR health status..; 3) pediatri* OR paediatri OR teenage* OR adolescent OR child
OR child* 4) 1 AND 2 AND 3. Medical Subject Heading (MeSH) terms were used
whenever possible. The references of relevant studies were used to identify potential
other studies not discovered upon initial search.

Inclusion criteria
Studies were considered for inclusion if: 1) child or parent-reported QOL or HRQOL was
the main outcome of the study; 2) study population was specific to or included children
with Duchenne Muscular Dystrophy (≤18); and 3) were published in the English
language.

2.2 Results
2.2.1

Overview of studies

Nineteen studies were identified that fit the inclusion criteria. The studies were published
between 2005 and 2013 and were conducted in the following countries: United States, the
Netherlands, Germany, China, Brazil, France, Australia, Italy, and Canada. Thirteen
measures of QOL or HRQOL were used; a summary of these instruments can be found in
Table 2.1. The majority of the generic instruments used are multidimensional, consisting
at least of physical, emotional and social domains, including: KIDSCREEN-52,
DISABKIDS, Pediatric Quality of Life Generic Core 4.0 (PedsQL), Child Health
Questionnaire-parent report (CHQ), Vecu Sante Percu par l’adolescdent (VSP-A). Some
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studies used instruments that examine an individual domain of HRQOL. For example, the
Personal Adjustment and Roles Scale-III (PARS-III) focuses only on psychological
adjustment and does not include questions pertaining to physical functioning. One of the
challenges of summarizing studies is the diversity of the instruments used. There is
heterogeneity among the instruments in their purpose and design. For example, all
instruments have unique domains, and some have no summary score. This makes it hard
to compare results across studies. However, the most commonly used instruments, the
PedsQL Generic Core 4.0 and the CHQ-50 Parent Report both have summary physical
and psychosocial scores, making them most comparable to one another.
Seventeen of the studies were cross-sectional and two were longitudinal, conducted over
the span of nine months and one year. Many studies (N= 8) had single-centre designs and
recruited participants through approaching patients in neuromuscular clinics. The sample
sizes of the studies ranged from 25 to 287. It should be noted, however, that some of
studies’ patient populations included adults with DMD or children with other types of
neuromuscular disorders (Grootenhuis et al., 2007; Mah et al., 2008; Orcesi et al., 2014;
Vuillerot et al., 2010).
Although almost all of the studies of HRQOL in children with DMD are descriptive,
some comparative analyses were completed. Four recurring themes were identified
among the studies: 1) comparison of HRQOL between boys with DMD and either a
healthy control group or a group with another chronic illness; 2) comparison between
sub-groups within the paediatric DMD sample; 3) investigation of relationship between
clinical measures of function and child or parent reported HRQOL; 4) and comparison
and agreement between child self-report HRQOL and parent reported HRQOL. Each of
the four themes will be discussed in detail below. A summary of major findings of all
studies can be found in Table 2.2.

Comparison to healthy peers or those with another illness
Ten studies compared HRQOL in boys with DMD to a healthy cohort, or children with
other chronic illnesses. Four of these studies (Bendixen et al., 2012; Henricson et al.,
2013; McDonald et al., 2010; Orcesi et al., 2014) recruited healthy controls along with
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their DMD sample, six studies used established normative data from the literature as their
healthy controls (Baiardini et al., 2011; Bray et al., 2011; Davis et al., 2010; Elsenbruch
et al., 2013; Opstal et al., 2013; Uzark et al., 2012).
Eight studies found that boys with DMD had significantly poorer physical HRQOL than
healthy boys and children with other types of chronic illnesses. Five studies reported that
boys with DMD had significantly lower psychosocial score than healthy controls
(Baiardini et al., 2011; Bendixen et al., 2012; Bray et al., 2011; Davis et al., 2010; C. M.
McDonald et al., 2010). None of the studies reported effect sizes, but the differences in
physical HRQOL score were consistently larger than differences in psychosocial score.
Houwen-van Opstal et al. (2013) reported that there were no significant differences in
HRQOL score between boys with DMD and healthy children, in any of the ten domains
of the KIDSCREEN-52, except the physical domain. Elsenbruch and colleagues (2013)
divided their sample into child and adolescent groups. In the children’s group, all
subscale scores as well as the total HRQOL score were significantly lower than the scores
of age-matched children with other chronic illnesses (p<0.05). In the adolescent group,
only the social inclusion subdomain score was significantly lower in boys with DMD
compared to normative data (p<0.01). Orcesi et al. (2014) developed a new HRQOL
instrument targeted at young children with neuromuscular illnesses, the Strips of Life
with Emoticons (SOLE), which only has an overall score and no domains scores.
Compared to healthy boys, the mean score for boys with DMD was significantly lower.
Overall, compared to healthy children or children with other chronic illnesses, boys with
DMD had significantly poorer HRQOL scores. This difference is most consistent in the
physical domain. In eight out of ten studies, boys with DMD had lower physical HRQOL
scores than healthy controls and children with other types of chronic illnesses, and this
deficiency was observed in both child self and parent proxy reports. Most of the studies
found that the psychosocial scores of boys with DMD are also lower than their healthy
peers.
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Comparison between subgroups
DMD is a progressive disease with inevitable physical deterioration. Thus, a natural
question is whether HRQOL declines with disease progression. This question would most
ideally be addressed through longitudinal studies where a group of patients is followed
over time. However, as HRQOL in DMD patients is a relatively new area of research,
almost all studies are cross-sectional. In cross-sectional studies, patients with different
disease severity have been compared to one another. Age is often used as a proxy for
disease progression given that generally, older children have more severe illness. Disease
groups may also be separated by ambulation status (ambulant or non-ambulant) or
ventilation status (does not require ventilation or requires ventilation).
Ten studies compared HRQOL stratified by disease severity. The most commonly used
questionnaire was the PedsQL Generic Core 4.0, which has three versions based on age:
ages 5-7, ages 8-12, and ages 13-17. In addition, the PedsQL inventory has disease
specific modules, including Neuromuscular and DMD modules. Disease specific
measures tend to be more sensitive when used to compare HRQOL across disease subgroups (Eiser & Morse, 2001c).
Three studies used the PedsQL 4.0 Generic Core scale and reported that younger boys
had significantly higher physical HRQOL score than older boys (Bray et al., 2010;
McDonald et al., 2010; Uzark et al., 2012). In contrast, another study reported that in
their sample of boys with DMD, those who were younger than 10 years of age did not
report significantly higher physical HRQOL than those who were older (Bendixen et al.,
2012). Two studies reported boys who were using wheelchair had significantly lower
physical domains scores than boys who were still ambulant (Baiardini et al., 2011; Davis
et al., 2010).
There is less consistency across studies that involve assessment of psychosocial HRQOL.
Four studies reported that there were no significant differences between older and
younger boys in psychosocial HRQOL scores (Baiardini et al., 2011; Bendixen et al.,
2012; Bray et al., 2011; McDonald et al., 2010). Similarly, Davis et al. (2010) reported
that there were no significant differences in psychosocial HRQOL scores between
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children who were using wheelchairs and those who were not. In contrast, Hendriksen et
al. (2009) found that the psychosocial adjustment score was positively associated with
age in a survey of parents of boys with DMD (p<0.001). As well, Uzark et al. (2012)
found that children in the oldest age group reported significantly higher psychosocial
score than children in younger age groups (p=0.05). Mah et al. (2008) surveyed the
parents of 109 children with various neuromuscular disorders, 24 of whom had Duchenne
or Becker Muscular Dystrophy, they found that children on ventilation support had
significantly lower physical HRQOL (p<0.001) and psychosocial scores (p=0.028)
compared to children not on ventilation.
Kohler et al. (2005) found that in their group of DMD patients, those who were ventilated
did not report a significantly lower physical or mental HRQOL scores than those who did
not require ventilation. However, the author used the Short Form-36, which was
designed to assess HRQOL in adults rather than in children.
In a longitudinal study, Simon et al. (2011) followed a group of Boys with DMD over
nine months and administered the Life Satisfaction questionnaire every three months, for
a total of four times. They divided their sample into four age groups, and found that life
satisfaction scores improved significantly in most domains over the follow-up period for
boys across all four age groups. However, the authors did not report the actual scores of
each age group at each time point but instead reported the average score over four time
points for each age group. This makes it difficult to confirm the conclusion these authors
drew. One major limitation of the study was that the questionnaire used was designed for
adolescents, but was used on children under 12 years of age, who made up majority of the
study sample. There was no psychometric evaluation to justify this deviation.
Overall, physical HRQOL in children who are at a more severe stage of the disease is
worse than children who are at a less severe stage. Disease severity is proxied by age, and
use of assistive devices such as wheelchairs and ventilation. Less consistent is the
relationship between disease severity and psychosocial HRQOL. Some studies
(Hendriksen et al., 2009; Uzark et al., 2012) found older children reported better
psychosocial HRQOL despite having more severe disease, while others (Baiardini et al.,
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2011; Bendixen et al., 2012; Bray et al., 2011; McDonald et al., 2010) report there are no
significant differences between older and younger children. However, it is worth noting
that no conclusions can be drawn on any causal relationship between disease severity and
HRQOL due to the cross-sectional nature of most studies. In addition, the studies have
generally had small sample sizes precluding more robust analyses such as regression
modeling to determine the relative contribution of these disease severity measures.

Correlation with clinical measures
Traditional outcome measurements used in clinical trials of DMD involve quantitative
strength and function. With the increasing recognition of the importance of patientreported outcomes such as HRQOL, some studies have examined the relationship
between clinical measures and HRQOL. There are two common groups of clinical
measures: measurement of strength and measurement of motor function.
The domains of the KIDSCREEN-52 (Opstal et al., 2013) and the DISABKIDS
(Elsenbruch et al., 2013) did not correlate well with clinical measures. The only
significant correlations were between the physical domain of the KIDSCREEN-52 and
the Vignos scale, a measure of upper body strength (r=-0.45, p=0.01); and between
emotional domain of the DISABKIDS and the Vignos scale (r=0.5, p=0.0490).
McDonald et al. (2010) found that only the physical domains of the parent-reported
PedsQL 4.0 Generic Core and the Paediatric Outcomes Data Collection Instrument
(PODCI) significantly correlated with functional measures. Similarly, in two separate
studies, Bray and colleagues (Bray et al., 2010, 2011) found that only the physical
domains of the CHQ-50 parent report (r=-0.38, P=0.03) and the physical domain of the
PedsQL correlated with the Vignos scale (r=-0.17; p=0.01). The 6-minute walk test is a
recently adopted outcome measure in clinical trials of DMD (NCT01462292). Henricson
et al. (2013) found that decline in 6-minute walk test over one year correlated
significantly with decline in PODCI score.
Vuillerot et al. (2010) examined well-being of a group of 43 adolescents with various
neuromuscular disorders, 19 of whom were DMD patients. They concluded that HRQOL
does not correlate with motor function.
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Overall, it appears that while the physical domains of some HRQOL measures correlates
significantly with commonly used clinical measures, neither the psychosocial domains
nor the overall HRQOL scores correlated with clinical end points. the examination of the
relationship between clinical measures and HRQOL is difficult challenging due to the
variety of HRQOL measures and motor strength and function measures being used by
investigators, reflecting the early and evolving nature of this area of research.

Comparison and agreement between child report and parent report
It has been well-recognized that assessment of both parent and child perspectives of a
child’s HRQOL is important, as there are often discrepancies between them (De Civita et
al., 2005; Eiser & Morse, 2001c).
Parents generally rate their child’s HRQOL lower than children themselves did (Bray et
al., 2010; Davis et al., 2010; Hu et al., 2013; Uzark et al., 2012), although no statistical
comparisons were conducted in these studies. This difference tends to be greater in the
psychosocial domains than the physical domain. Lim et al. (2014) and colleagues did find
that parents reported significantly lower HRQOL on all domains of the PedsQL 4.0
Generic Core than their sons.
Eight studies included both child self-reports and parent proxy-reports, and of these, five
studies examined concordance between child and parent reports. Parent and child
concordance is determined by intraclass correlation coefficient (ICC). For the purposes of
this review, an ICC of ≤ 0.40 would be considered poor, 0.41 to 0.75 would be
considered moderate, and > 0.75 would be excellent (Uzark et al., 2012).
In studies that used the PedsQL Generic Core 4.0 questionnaire (Bray et al., 2010; Davis
et al., 2010; Uzark et al., 2012), only the school domain had moderate concordance, while
other domains had poor concordance. Davis et al. (2010) found that all subdomains of the
English PedsQL 3.0 Neuromuscular have poor parent-child concordance. Hu et al. (2013)
tested the Chinese version of the same questionnaire and found that for 50 child-parent
pairs, the ICC of the overall score and subdomains were moderate. Lim et al. (2014)
found that by both classical test analysis, which examines scale-level agreement, and
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Rasch analysis, which examines item-level agreement, there was better concordance
between children and parents on the physical scale than psychosocial scale.
Overall, parents tend to rate their child’s HRQOL as worse than children themselves do,
and the concordance between parent and child is in the poor to moderate range with the
majority of domains and total scores in the poor range. The more observable aspects of a
child’s life, such as the school function tended to yield higher concordance.

Discussion and limitations of previous studies
The existing literature on HRQOL in boys with DMD offers some useful preliminary
information, but, there are several limitations that must be taken into account in
interpreting the findings. There is heterogeneity across studies with regards to the
definition and constructs of QOL and HRQOL. Some measures focus only on
individuals’ feelings about their well-being (PARS-III, LSI-A), while other instruments
are closer to measures of health status in that the questions evaluate the extent of a
problem has occurred (CHQ and PedsQL questionnaires). Furthermore, it is difficult to
compare the results across measures that have different domains, particularly if they do
not have summary score(s). Fortunately, the most commonly used questionnaires are
CHQ and PedsQL, both of which have physical and psychosocial summary scores,
making it easier to compare the findings.
Many of the studies used convenience sampling and drew participants from local
clinic(s). Given the severity of the disease, it is reasonable to assume that almost all boys
with DMD are managed at a tertiary-care clinic, thus patients recruited through such
clinics are likely representative of the DMD population. However, most studies did not
report a response rate and it is unclear whether the respondents differ from those who
chose not to participate. Moreover, there has not been a previous study in Canada of boys
with DMD. Due to the rarity of DMD, it is difficult to employ a population-based random
sampling procedure. A registry based study may be an alternative to population based
random sampling.
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Most of the studies had relatively small sample sizes, with ten of the 18 studies having a
sample size of 50 participants or less. When subgroup comparisons are made, the sample
sizes became even smaller. Thus the lack of any significant differences in comparison
could be due to insufficient power. Additionally, of all HRQOL measures, only the
PedsQL questionnaires has been validated specifically in a paediatric DMD population
(Davis et al., 2010). The reliability and validity of other measures in this population is
unknown. Some studies have applied questionnaires designed for adults (Kohler et al.,
2005) or adolescents (Simon et al., 2011) to children, without any psychometric
evaluation of their appropriateness.
Many of the studies did not report their results comprehensively. Some reporting issues
include lack of p-value being reported (Opstal et al., 2013), not computing a summary
score despite one being available for the questionnaire used and displaying results in
graphs with no error bars (Bray et al., 2010).
In four of the studies (Grootenhuis et al., 2007; Mah et al., 2008; Orcesi et al., 2014;
Vuillerot et al., 2010), boys with DMD were part of a sample that included children with
other types of neuromuscular disorders, making it hard to elucidate specifically the
HRQOL of boys with DMD. Some studies excluded boys younger than 8 years old
(Davis et al., 2010; Elsenbruch et al., 2013), or boys who have lost ambulation
(Henricson et al., 2013; McDonald et al., 2010). The time around initial diagnosis and
loss of ambulation, may be particularly vulnerable times for boys with DMD and should
receive more focus. Finally, not all of the studies assessed HRQOL from both parent and
child perspectives, and only three studies used disease-specific questionnaires (Davis et
al., 2010; Hu et al., 2013; Uzark et al., 2012).
A multitude of QOL and HRQOL measures were used. Most studies that used the
PedsQL questionnaires designated it as a measure of HRQOL, two studies designated it
as QOL (Bendixen et al., 2012; Mah et al., 2008). The KIDSCREEN-52, DISABKIDS,
PODCI and TACQoL were considered as HRQOL measures; while the VSPA, LSI-A,
Short Form-36 and SOLE were considered to be QOL measures. The CHQ-50 was
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considered to be a QOL measure by one study (Baiardini et al., 2011) and health status by
another study (Bray et al., 2011).

2.2.2

Conclusions

From the existing literature, it is apparent that the HRQOL of boys with DMD is poorer
than that of their healthy peers, particularly in the physical domain. Within the DMD
sample, boys with more severe disease consistently reported poorer physical HRQOL
than boys with less severe disease; such a difference was not as consistent for
psychosocial HRQOL. Similarly, while the physical domains of HRQOL instruments
correlated well with clinical measures of functioning, psychosocial domains did not.
Finally, the parent and child concordance for most measures of HRQOL was poor. It is
important to determine whether these findings can be replicated in future studies that
overcome some of the shortcomings of previous work. A comprehensive study that
examines QOL and HRQOL from children’s and parents’ perspectives, using validated
generic and disease specific questionnaires and one that spans the entire paediatric DMD
age range would help researchers and clinicians gain more insight into the subjective
well-being of children with DMD. Furthermore, determining child or family factors that
are associated with HRQOL could help clinicians and researchers identify potential risk
factors for poor HRQOL and provide appropriate intervention.
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Table 2-1 Summary of quality of life and health-related quality of life instruments
used by studies reviewed
Instrument
Dimensions/domains
Scoring
Studies
KIDSCREEN-52
Dutch version

DISABKIDS
German version
Pediatric
Quality of Life
4.0 Generic
Core (PedsQL
4.0 Generic)
English and
Chinese
versions
Paediatric
Outcome Data
Collection
Instrument
(PODCI)

Physical, psychological, moods/emotions,
self-perception, autonomy, parent
relations/home life, financial resources,
social support/peers, school
environment, social acceptance.
Independence, emotion, social inclusion,
social exclusion, physical limitation,
treatment
Physical, emotional, social and school
functions

Scores on ten
domains

(Opstal et al.,
2013)

No total score
Scores on ten
domains and
total score
Scores on four
domains
2 summary scores:
Physical score;
Psychosocial score
(emotional, social
and school functions
combined)
Total score
Scores on five
domains
Global functioning
score is mean of all
domains excluding
happiness.

(Elsenbruch et al.,
2013)

Motor functioning, physical symptoms,
social functioning, cognitive functioning,
positive emotions, negative emotions,
autonomy
Vitality, leisure, relationship with parents,
relationship with friends, relationship
with teachers, body image, school
performance, physical and psychological
wellbeing

Scores on seven
domains
No total score

(Grootenhuis et
al., 2007)

Scores on 9 domains
No total score

(Vuillerot et al.,
2010)

Physical Functioning, Role/Social
Limitations – Physical,
General Health Perceptions, Bodily
Pain/Discomfort, Family Activities,
Role/Social Limitations – Emotional,
Role/Social Limitations– Behavioral,
Parent Impact Time, Parent Impact
Emotion, Self-Esteem, Mental Health,
Behavior, Family Cohesion, Change in
health

Scores on 15
domains

(Baiardini et al.,
2011; Bray et al.,
2011)

Upper extremity, transfer/basic mobility,
sports/physical function, pain, happiness,
and global functioning

(Davis et al.,
2010; Henricson
et al., 2013; Hu et
al., 2013; Mah et
al., 2008;
McDonald et al.,
2010; Uzark et al.,
2012)
(McDonald et al.,
2010)

English
TACQoL
Dutch

Vecu Sante
percu par
l’adolescent
(VSPA)
French
Child Health
Questionnaire
Parent Form 50
(CHQ-50)
English version

2 summary scores:
physical and
psychosocial
No total score
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Personal
Adjustment and
roles Skills Scale
(PARS-III)
Dutch
Life Satisfaction
Index for
Adolescents
(LSI-A)

Peer relations, dependency, hostility,
productivity, anxiety/depression, and
withdrawal

Scores on six
domains

(Hendriksen et al.,
2009)

No total score

General wellbeing, interpersonal
relationship, personal development,
personal satisfaction, recreation

Scores on five
domains

(Simon et al.,
2011)

No total score

English and
Dutch versions
Short Form 36

Strips of Life
with Emoticons
(SOLE)
Italian
PedsQL
Neuromuscular
Module
English and
Chinese
Versions
PedsQL DMD
module

Vitality, physical functioning, bodily pain,
general health perceptions, physical role
functioning, emotional role functioning,
social role functioning, mental health

Scores on eight
domains

33 individual items that assess how a
child feels at different times in a typical
day

Total score of all 33
items

(Orcesi et al.,
2014)

About My Neuromuscular Disease,
communication, About our family
resources

3 domain scores

(Davis et al.,
2010; Hu et al.,
2013)

Daily Activities, Treatment, Worry,
communication

4 domain scores

No total score

Total score

No total score
English version

(Kohler et al.,
2005)

(Uzark et al.,
2012)
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Table 2-2 Summary of studies reviewed
Citation
Baiardini et al., 2011

Study design and sample
characteristics
Cross-sectional;
DMD sample N=27, mean
age 11.4

HRQOL measure used
Child Health Questionnaire
50- Parent Form

Major findings
Parents reported significantly lower
physical, psychosocial score than
normative sample

Parent-report
Neuromuscular clinics in
Italy
Bendixen et al., 2012

Cross-sectional;
DMD sample N=50; mean
age 8.0 years (range 5-17)
healthy sample N=25

PedsQL 4.0 Generic Core
Self- and parent- report

Neuromuscular clinic in the
United States (Florida)

Bray et al., 2010

Cross-sectional;
DMD sample N=35, mean
age 12.5 (range 9-17
Recruited through
neurogenetics clinics and
community newsletters in
Australia

Use of wheelchairs and ventilation were
significantly associated with lower
physical functioning HRQOL
HRQOL was lower for boys with DMD in
the physical, social and school domains,
and the overall score. There was no
significant difference in the emotional
domain
Participation level in physical and social
activities is not correlated to HRQOL in
boys with DMD.

PedsQL 4.0 Generic Core
Self- and parent- reports

Older boys had significantly lower
participation level, but not HRQOL than
younger boys
Parent-child concordance range from
poor to modest in different domains,
greatest in school domain
Self-reported scores significantly
correlated with physical domain and
Vignos scale
Younger boys with DMD had significantly
higher physical domain score than older
boys
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Bray et al., 2011

Cross-sectional;
DMD sample N=34, mean
age 9.9 (range 5-18)

Child Health Questionnaire
50-Parent Form
Parent-report

Parents reported significantly lower
physical, psychosocial score than
normative sample and sample of children
with Charcot-Marie-Tooth disease

Cross-sectional;
DMD sample N=44, mean
age 12.9 (range 8-18)

PedsQL 4.0 Generic Core
and PedsQL 3.0
Neuromuscular modules

Parents experienced greatest stress
during disease transition points such as
loss of ambulation
Parent and child reported HRQOL
significantly lower than normative
sample

Neuromuscular clinics in the
United States

Self- and parent- reports

Three urban paediatric
hospitals in Australia

Davis et al., 2010

Elsenbruch et al., 2013

Grootenhuis et al., 2007

Cross-sectional;
DMD sample N=50, mean
age 15.4 years (range 8-23)
Control derived from 1,152
children with different
chronic health conditions
Single paediatric neurology
clinic in Germany
Cross-sectional
Muscular dystrophy sample
N=40, 36 are DMD patients
mean age 12.6 (range 8-17)
Dutch Neuromuscular
centres

DISABKIDS chronic generic
module for children and
adolescents; Short Form-36
for young adults

The PedsQL 3.0 Neuromuscular module
is reliable and valid measure of HRQOL in
the paediatric DMD population
Full time wheelchair users had lower
physical HRQOL in both generic and
neuromuscular specific modules
In children, HRQOL score of boys with
DMD in all domains were lower than
boys with other chronic illnesses. In
adolescents, only social inclusion domain
had lower score.

Self- and parent- report
No correlation between total HRQOL
score and Vignos function score.
TACQoL children for under
16 year olds
TACQoL adult for 16 and
older

Children and adolescents with muscular
dystrophy reported significantly lower
QOL in ‘motor functioning’ domain than
healthy peers

Self-report

Better ‘physical symptoms’ score, but
worse motor functioning score than
healthy peers
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Hendriksen et al., 2009

Hu et al., 2013

Henricson et al., 2013

Kohler et al., 2005

Lim et al., 2014

Cross-sectional
DMD sample N=287, mean
age 10.9 (range 5-18)

Personal Adjustment and
Role Skills Scale (PARS-III)

The PARS-III is a reliable and valid
measure in the paediatric DMD
population

the Netherland and U.S

Parent report

PARS-III total score was not significantly
different in DMD compared to males
with other chronic medical conditions

Cross-sectional;
DMD sample N=56
Mean age 7.54 (range 2-13)

Chinese version of PedsQL
4.0 Generic Core and
Neuromuscular 3.0 module

Tertiary hospitals in urban
China
Longitudinal
DMD sample N=24
ambulatory boys mean age
7.9 (range 4-12)
Controls N=36

Self and parent-report

Neuromuscular clinics in the
United States (California)
Cross-sectional
DMD sample N=35 mean
age 17 (range 8-33)
Cross-sectional
DMD sample N=63 parentchild pairs
Mean age 10.3 (range 5-16)
United States

PedsQL 4.0 Generic Core
PODCI

PARS-III total score positively correlated
with increase in age
The Chinese version of PedsQL 4.0
General core and Neuromuscular is
feasible, reliable and valid
Agreement between parent and child is
moderate.
The 6-minute walk test and the PODCI
global scale, and transfer scale declined
significantly over one-year interval.
One-year change in PODCI scores are
significantly correlated with one-year
change in 6 minute walk test

Short Form-36
Self-report
PedsQL 4.0 Generic Core

Neither physical nor mental summary
score in DMD patients was not found to
be correlated with physical impairment
or FVC
Parents reported significantly lower
physical and psychosocial HRQOL

Self and parent-report
Classical test theory analysis and Rasch
analysis found the agreement between
children and parents in physical domain
was better than psychosocial domains.
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Mah et al., 2008

McDonald et al., 2010

Cross-sectional
Neuromuscular sample
N=109, 24 are DMD or
Becker MD, mean age 10.5
Single Neuromusclar centre
in Canada
Cross-sectional;
DMD sample N=52
ambulatory boys (age range
4-17)
Control sample N=36

PedsQL 4.0 General Core
Parent-report

PedsQL 4.0 Generic Core
Module

Opstal et al., 2013

Orcesi et al., 2014

(Simon et al., 2011)

Recruited from Dutch
Duchenne Parent Database
Cross-sectional;
DMD sample N=43 (out of
78 neuromuscular patients)
Mean age 8.6 years (range
5-13)

Parent reported HRQOL in both
questionnaires are lower than those of
controls

PODCI
Parent-report

Neuromuscular clinics in the
United States
Cross-sectional;
DMD sample
N= 40, mean age 11.5 years
(range 8-20);
Control group N=22,827

Children who required ventilation had
significantly lower overall HRQOL than
children not on ventilation

KIDSCREEN-52
Self-report and parentreport

The physical function domain of PedsQL
and of PODCI correlated with age and
some clinical measures of strength
Apart from physical domain, HRQOL in
Boys with DMD not significantly different
from that of healthy boys.
Significant correlations between physical
domain and some functional scales

Newly developed Strips Of
Life with Emoticons (SOLE)
questionnaire
Self- and parent- report

Six tertiary centres in Italy
Longitudinal
Life Satisfaction Index for
DMD sample N=95 (age
Adolescents
range 5 to 17)
Single neuromuscular centre Self-report
in Brazil

DMD patients reported lower QOL than
healthy controls
No significant correlation found between
functional disability and SOLE total score

Boys with DMD showed increase in selfperceived QOL in most domains of the
Life Satisfaction Index over the nine
month period of the study
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Uzark et al., 2012

Cross-sectional;
DMD sample N=203 mean
age 10.4 years (age range 517)

PedsQL 4.0 Generic Core
and DMD module
Self- and parent-report

Older boys self-reported psychosocial
score was significantly higher than that
of younger boys.

Neuromuscular clinics in the
United States (Michigan)

Vuillerot et al., 2010

Cross-sectional;
Neuromuscular sample
N=43, 19 are DMD
Mean age 13.8 years (range
10-17)
Single neuromuscular centre
in France

Parent and child reported total and
subdomain scores were significantly
lower than those of healthy children.

Vecu Sante Percu par
L’adolescent (self-perceived
health states in adolescents)
Self-report

The PedsQL DMD module is reliable and
valid
Teens with a neuromuscular disorder did
not report lower score than nondisabled
group
QOL scores did not correlate with
physical impairment
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Chapter 3
3

Methods

This chapter describes the process of data collection, data management strategies and
statistical analyses related to each objective. The properties of the measures and variables
used in the study are also reviewed.

3.1 Data Source, Study Design and Data Management
3.1.1

Data source

Participants were recruited through the Canadian Neuromuscular Disease Registry
(CNDR), a national registry that collects demographic and medical information from
people living with a neuromuscular disease, including DMD, across Canada.
The CNDR was implemented with the objective of fostering collaborative research and
facilitating planning of clinical trials. Recruitment at the two lead sites, Calgary and
London, began in June 2011. The National Office for the CNDR is based at the
University of Calgary in Alberta, Canada. Nine paediatric neuromuscular clinics across
Canada are currently enrolling patients with DMD into the registry. Patients are
approached for enrollment during routine clinic visits. Upon enrollment, patients indicate
whether they want to be contacted for research studies in the future. As part of the
registry, demographic and medical information are collected at the initial recruitment
visit and then all follow-up visits. At each clinic visit, the treatment team completes the
CNDR data collection forms, which are then uploaded onto a secure web-portal. All
personnel who complete data entrance at each site are trained by the CNDR national
coordinator. As well, there is a detailed data reference manual which outlines the
requirement for individual fields. Data entry is reviewed on a weekly basis by the
National Office and any errors detected are reported back to the local sites for correction.
Finally, data are audited on a regular basis by the National Office (Korngut et al., 2013).
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3.1.2

Data collection

Ethics approval was obtained from the Research Ethics Board at Western University and
the CNDR. A copy of the approval notice can be found in Appendix A. The CNDR
national office coordinated the mail-out to all eligible families who indicated they were
interested in participating in research. Due to the confidentiality protocol for the CNDR,
only the national office has access to the addresses and identifying information of these
families. A set of unique IDs was generated for this study, and only the CNDR national
office has the list matching IDs to CNDR data.
Inclusion criteria:
1. Enrollment in CNDR and patient (or parent) has indicated interest to be contacted for
research studies
2. Males between ages of 4-18 years of age;
3. A confirmed diagnosis of DMD in the CNDR database. The definition is confirmed
by genetic testing or absence of dystrophin on muscle biopsy, and a phenotype
consistent with DMD as judged by the treating physician;
4. Availability of primary care giver to complete the parent questionnaire.
Exclusion criteria:
1. Any significant co-morbid medical diagnosis not related to DMD;
2. Inability to comply with study protocol (e.g. lack of language skills to complete
questionnaire)
Questionnaires were compiled in London and forwarded to the national office for mailout in June 2013. There were two separate questionnaire booklets, one for the child to
complete as self-report, one for the parent to complete as proxy-report. Parents and
children were instructed to complete the questionnaires independently. In the case where
the child was unable to complete the questionnaire on his own, parents were instructed to
read the questions to their child verbatim and not guide the child in answering the
question. Included with the questionnaires were a letter of information for parents and
assent letter for children, describing the study (Appendix B). Implied consent was
assumed for this study if the participant returned the questionnaires. One week after the
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initial mail-out, a reminder postcard was sent out to all families. Four weeks later, a
reminder package, containing the same elements as the initial package was sent to those
who had not responded. Eight weeks after the initial mail-out, another reminder package
was sent to those who had not yet responded. A copy of the reminder postcard and the
letter accompanying the reminder package can be found in Appendix C. This method,
consistent with the Dillman’s Tailored Design method was used to maximize the
response rate (Dillman, 1978).

3.1.3

Data management

Questionnaires were initially returned to the national CNDR office at the University of
Calgary, Canada where the respondents were cross-referenced against the master list to
keep track of who had responded. Returned questionnaires were forwarded from Calgary
to London. All data entry was completed at London Health Sciences Centre, Victoria
Hospital. Data were entered into Statistical Package for the Social Sciences (SPSS)
Statistics 21. Data verification was done by another research assistant, where 10% of the
questionnaires were verified. The error rate was less than one percent, and errors were
corrected by checking against the original questionnaire.

3.2 Measures
The boys with DMD and their parents completed questionnaires that assessed the child’s
QOL and HRQOL. The boys and their parents also completed a questionnaire that
assessed the child’s fatigue. Parents answered additional questions on child
characteristics and family information which included demographic information and the
Family Inventory of Life Events (FILE) checklist. Instructions were provided at the front
of the child and parent questionnaires to aid completion, these instructions can be found
in appendices E to G. Parent report version of the various QOL and HRQOL measures,
the fatigue measure, the demographic information measure and the FILE can be found in
appendices H to N. All measures used are described below.
Apart from child and parent completed information, demographic and medical
information recorded in the CNDR database were also obtained, they are described in
more detail later in the chapter.
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3.2.1

QOL and HRQOL measures

Four different measures were used to measure QOL and HRQOL. The Quality of My
Life (QoML) Questionnaire measured both QOL and HRQOL with single-item
statements. Three Pediatric Quality of Life Inventory (PedsQL) questionnaires were used
as multidimensional measures of HRQOL with various degrees of disease specificity. A
visual schematic representation of the QOL and HRQOL measures can be found in
Figure 3.1, a summary of all measures used can be found in Table 3.1.

Quality of My Life Questionnaire
The Quality of My Life (QoML) Questionnaire was initially developed to measure
overall QOL and HRQOL as distinct constructs in children with rheumatoid arthritis
(Feldman et al., 2000). The questionnaire consists of two single-item statements
measured on visual analog scales (VAS). The first item states ‘overall, my life is…’ and
the second states ‘Considering my health, my life is….’. Answers are marked along a
100mm line for each question, with 0 being ‘the worst’ and 100 being ‘the best’. Child
respondents assess their own QOL and HRQOL while parent respondent assess their
child’s QOL and HRQOL. For this study, an item was removed from the original QoML,
which was a question that assesses temporal change in QOL which asks the respondents
to indicate ‘since the last time I was here my life is…’ better or worse, on a 5-point likert
scale. This item was removed from this study because the questionnaires were done in a
cross-sectional manner and there was no basis for a temporal comparison. Convergent
validity of the QoML has been established in the paediatric rheumatology population
(Feldman et al., 2000; Gong et al., 2007). The QoML has also been used in other
populations, such as children with neurological impairment and children with hemophilia
(Mahant et al., 2009; Revel-Vilk et al., 2004). A copy of the QoML can be found in
Appendix H.

Pediatric Quality of Life Inventory generic core module and disease
specific modules
The PedsQL Inventory is a repertoire of generic and disease-specific modules that
measure HRQOL in children and adolescents. All modules in the PedsQL inventory
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contain multiple items which are grouped into domains. Each item asks the extent to
which an event has been a problem for the child in the past month. For example, a
question in the physical domain of the PedsQL 4.0 Generic Core asks ‘In the past month,
how much of a problem have you had with participating in sports activity or exercise’.
Each item is measured on a five-point likert scale that ranges from 0-4 (0=never,
1=almost never, 2=sometimes, 3=often, 4=almost always). All items are reverse scored
and linearly transformed into scale out of 100 (0=100, 1=75, 2=50, 3=25, 4=0) such that
higher score indicates better HRQOL.
The PedsQL Inventory modules are composed of parallel child-self report and parentproxy reports, and are divided into three age groups: young child (5-7 years old); child
(8-12 years old) and teen (13-18 years old). It should be noted that in our study we
administered the young child report to children aged 4 years old (n=6), to increase our
sample size, particularly in the number of children who were recently diagnosed. The
content of the items is identical, differing in language modified to be developmentally
appropriate. For young children’s self-report, the 5-point likert scale is reduced to 3-point
likert scale, (0=never, 2=sometimes, 4=almost always). Due to the young age of these
children, parents were asked to act as interviewers to their child and given specific
instructions (Appendix E). Domain scores are computed as a sum of items divided by
number of items answered. If more than half of items on a particular domain are missing,
the domain score is not calculated. An overall score is calculated as the sum of items
divided by total number of items.
Generic Core Module
The PedsQL 4.0 Generic Core module is a generic measure of HRQOL, it has been
widely used in healthy children and children with various disorders (Varni et al., 2001;
Varni et al., 2003, 2007b). It has been found to be valid and reliable specifically in the
paediatric DMD population (Davis et al., 2010). It consists of 23 items, grouped into
four domains: eight questions in physical domain, and five questions in each of
emotional, psychological and school domains.
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In addition to domain scores and the overall score, two summary scores are also
calculated. The physical domain score is also the physical summary score, and the
emotional, social and school domains make up the psychosocial summary score. The
parent proxy-report version of PedsQL 4.0 Generic Core module can be found in
Appendix I.
Neuromuscular module
The PedsQL 3.0 Neuromuscular module was developed in particular to measure
HRQOL in children with neuromuscular disorders, including those with DMD (Davis et
al., 2010). There are 25 items grouped into three domains: About my/my child’s
neuromuscular disease (17 items), Communication (3 items) and About Our Family
Resources (5 items). Each domain generates a score and there is also an overall score.
The young child self-report version does not contain the Communication and About Our
Family Resources domains. The Neuromuscular module has been tested primarily in a
group of children with spinal muscular atrophy (SMA), which is another type of
paediatric neuromuscular illness (Iannaccone et al., 2009), as well as a group of 44 boys
with DMD and been found to be feasible, reliable and valid (Davis et al., 2010). The
parent proxy-report version of PedsQL 3.0 Neuromuscular module can be found in
Appendix J.
DMD module
The PedsQL DMD module was developed as a more DMD-specific measure of HRQOL
(Uzark et al., 2012). It consists of 18 items, grouped into four domains: Daily Activities
(5 items), Treatment (4 items), Worry (6 items) and Communications (3 items). There is
no DMD module for young child self-report. It was developed simultaneously with the
Neuromuscular module, and has been found to be feasible, reliable and valid (Uzark et
al., 2012). The scoring instruction for this module precludes calculation of a total score,
however, upon contacting the module developers, it was deemed appropriate to calculate
a total score. The parent proxy-report version of PedsQL DMD module can be found in
Appendix K.
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Missing data
The percent missing for each question in the child-reported PedsQL questionnaires
ranged from 2.3% to 8.2%, with most questions having 2-3% missing values. The
questions that had a higher missing percentage were deemed ‘not applicable’ by some
children. For example, the question ‘how much of a problem have you had with running’
was deemed as not applicable by some children who had lost ambulation, some left it
blank and wrote ‘not applicable’ next to the question. Computation of PedsQL domain
scores only requires at least half of the questions in a given domain to be non-missing;
percent missing of domains scores ranged from only 2.3% to 3.5%. In the parent reported
PedsQL questionnaires, the percent missing for each question ranged from 0 to 4.1%. The
percent missing for domain scores range from 0 to 2.1%.
Initially, it was found that around 30% (N=25) of boys with DMD and their parents did
not complete the Quality of My Life questionnaire. This single-page questionnaire was
sent out again, with more detailed instructions, to those who did not complete it initially.
A copy of the letter accompanying the additional mail-out can be found in Appendix D.
Nine child self-reported QoML and fifteen parent-reported QoML were returned after
mailing of single-page QoML questionnaire. Items missing in the demographic portion of
the questionnaire were filled if such information could be found elsewhere (e.g. child’s
date of birth can be obtained from the CNDR). Missing data on the PedsQL were handled
according to guidelines of the questionnaire developers.

3.2.2

Child characteristics and family information

Child characteristics
In addition to the QOL and HRQOL questionnaires, boys with DMD and their parents
also assessed the child’s level of fatigue, which was measured via the PedsQL 3.0
Multidimensional Fatigue module. It has three domains, with six items in each: General
Fatigue, Sleep/Rest Fatigue and Cognitive Fatigue. It has been validated in paediatric
cancer (Varni et al., 2002) and rheumatology (Varni et al., 2004) populations, among
other diseases. It was scored the same as the PedsQL HRQOL modules, where
respondents indicated how much of a problem the boy with DMD had with a fatigue-
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related event. The scores were then reverse coded so that higher scores indicate less
fatigue. A copy of the parent reported PedsQL 3.0 Multidimensional Fatigue module can
be found in Appendix L.
The remainder of the child characteristics questions were adapted from the Health
Related Quality of Life in Children with Epilepsy Study (Speechley et al., 2012), with
permission of the Principal Investigator. Parents were asked to indicate whether their
child has a comorbid condition (asthma, cystic fibrosis, diabetes, cerebral palsy, epilepsy
or cancer); a developmental or mental condition (developmental delay, a learning
disability, Attention Deficit Disorder or Attention Deficit Hyperactive Disorder, Autism,
pervasive development disorder or Asperger’s syndrome, oppositional defiant disorder,
conduct disorder, depression and anxiety); whether child has needed and received extra
help with school work (special education, speech language therapy, occupational therapy,
medication or therapy for behaviour problems and medication or therapy for emotional
problems). Parents were also asked to give their child’s month and year of birth. A few
questions that were DMD specific were added to this questionnaire: Is your child
currently involved in any clinical trials or other research studies for his DMD? Was your
child diagnosed with DMD less than one year ago? Is your child able to walk (If no, did
your child stop walking less than one year ago or greater than one year ago?)

Family characteristics
The child’s family’s characteristics were collected through parent questionnaires and
included socio-demographic information including parents’ current marital status, current
employment status, highest level of education completed, household income and other
household members who currently reside with the child with DMD. Household income
was divided into 13 categories: less than $5000, $5,000-$9,999; $10,000-$14,999;
$15,000-$19,999: $20,000-$24,999; $25,000-$34,999; $35,000-$49,999; $50,000$74,999; $75,000-$99,999; $100,000-$149,999; $150,000-$200,000, over $200, 000, and
‘don’t know’. Parents also completed the Family Inventory of Life Events (FILE), which
was a 71 item of list of potential stressful events that a family may have faced. Each item
is answered with either ‘yes’ or ‘no’ to indicate whether that particular event has occurred
in the past year (McCubbin, 1996). Each item has a corresponding value if it is answered
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with ‘yes’, with higher scores assigned to events causing more stress (e.g. 99=death of
child). If an item was answered with ‘no’, it received a score of zero. The total score was
calculated as a sum of all items. The child characteristics and family characteristics
questionnaire can be found in Appendix M, and the FILE can be found in Appendix N.

3.2.3

Registry information

Medical information obtained from CNDR database included: forced vital capacity
(FVC), left ventricular ejection fraction (LVEF), ambulation status (yes or no),
wheelchair use status (never, intermittent, full-time), scoliosis status (yes or no), steroid
treatment (never, past use, current use), non-invasive ventilation (yes or no), invasive
ventilation (yes or no), cardiac medication (yes or no), type of genetic mutation, and date
of genetic test. The child’s date of birth was also obtained to confirm date of birth
reported by parents. In cases of discrepancy, the date of birth in registry was used.

3.3 Statistical Analyses
For all statistical analyses SAS software version 9.3 was used. A two-sided p-value <0.05
was considered to be statistically significant unless otherwise stated.

3.3.1

Description of sample characteristics

Univariate analyses were used to examine characteristics of the sample (mean and
standard deviation for continuous variables, frequencies and percentages for categorical
variables). Bivariate analyses (t- and χ2- tests) were used to determine whether nonrespondents were different from respondents on clinical characteristics obtained from the
CNDR database.

3.3.2

Describe the QOL and HRQOL in boys with DMD in Canada
from both children’s and parents’ perspectives (Objective 1).

The medians, means and standard deviations of child self-reported and parent proxyreported QOL and HRQOL scores of boys with DMD were calculated. As references,
scores of healthy children (Varni et al., 2003) and scores of a sample of children with
SMA, obtained from literature, were also reported.
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3.3.3

Examine the relationship between QOL and HRQOL
(Objective 2).

The relationship between the single-item measures of QOL and HRQOL were examined
with simple linear regression. To ensure that any relationship found between single-item
QOL and single-item HRQOL is not due to similarity in design between these two
measures (i.e. due to common method variance), the association between QOL and a
multidimensional measure of HRQOL (PedsQL Generic Core total score) was examined
with Spearman correlation. The association between the single-item measure of HRQOL
and multidimensional measure of HRQOL was also examined with Spearman correlation.

3.3.4

Explore child and family characteristics that contribute to any
difference between QOL and HRQOL (Objective 3).

Logistic regression was used to assess whether any child clinical or family characteristics
distinguished those who rated QOL to be higher than HRQOL from those who did not.
We decided to approach this objective by dividing our sample into two groups: boys and
parents who rated QOL to be ‘much’ higher than HRQOL, and children and parents who
did not rate QOL to be ‘much’ higher than HRQOL. QOL was considered much higher
than HRQOL if the difference between them was in the top 25% of the sample. There
was no guidance from literature on what constitutes a meaningful difference between
QOL and HRQOL, thus we made the arbitrary decision, based on the distribution of the
values in our sample, to dichotomize our outcome in this manner. The characteristics
tested in the multivariable logistic regression are presented in Table 3.1, they were: age of
child, fatigue level, ambulation status, presence of at least one mental or developmental
disorder, total household income, parental education, and family inventory of life events
score. Fatigue score and FILE score were presented in intervals of 10 and 50,
respectively, to reflect more meaningful levels of change.

3.3.5

Explore associations of child and family characteristics with
multidimensional measures of HRQOL (Objective 4)

To model the relationships of child and family characteristics with HRQOL,
multivariable linear regression with backwards elimination was used. Our study was
exploratory in nature, given that there was limited past literature on which to base our
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selection of variables. As such, various measures of disease severity and other important
clinical variables were selected for modeling based on clinical expertise. However, no
factors were considered to be primary predictors of interest. Because of the nascent
nature of our multivariable analysis, statistical regression (i.e. backwards elimination)
was deemed as the appropriate regression method (Tabachnick & Fidell, 2013). Child and
family characteristics were first examined individually via simple linear regressions.
Those that were significant at the p<0.30 level entered the maximum model. After
backwards elimination, only the variables that contributed significantly to the regression
(p<0.10) were kept in the final model. The entrance and retaining criteria for p-values
were decided upon after consulting literature and examining the data (Maldonado &
Greenland, 1993; Mickey & Greenland, 1989).
The variables that were tested were: age of child, wheelchair status, scoliosis status,
steroid usage, forced vital capacity (FVC), left ventricular ejection fraction (LVEF),
having at least one developmental or mental disorder, self- or parent-perceived fatigue
level (measured by PedsQL 3.0 Multidimensional Fatigue scale), family inventory of life
events (FILE) score, annual household income and parent’s highest level of education.
Clinical factors, such as wheelchair status and FVC, were chosen based on clinical
experience and existing literature (McDonald et al., 2010). Demographic factors, namely,
parental education and annual household income were included in the regression model
as they had been shown to be associated with children’s HRQOL (Rueden et al., 2006).
The FILE measure had also been shown to be a significant predictor of HRQOL in
chronically children, thus it was included as a potential determinant of HRQOL
(Speechley et al., 2012). Similarly, fatigue was associated with HRQOL in the pediatric
cancer population (Meeske et al., 2004) and thus examined in our sample. A separate set
of analyses was carried out to determine the effect of FVC. Data on FVC were available
for 67 children, and as SAS uses list-wise deletion, the sample size for the regression
analyses would have been reduced to 67. Thus, one set of analyses was done with all
variables in the model except for FVC to test for joint effect of these variables, then a
separate set of analyses was carried out to assess the effect of FVC in the 67 children
with a FVC value. LVEF was another variable that was influenced by list-wise deletion,
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however, it did not meet the entrance criteria to enter into the maximum model, and thus
was not relevant to the final models. The variables are presented in Table 3.3.

3.3.6

Compare QOL and HRQOL of ambulant boys who were
diagnosed recently to those who were diagnosed longer ago
(Objective 5).

QOL and HRQOL scores of ambulatory children who were diagnosed after 2012 were
compared to ambulatory children who were diagnosed before 2012 using Kruskal Wallis
tests.

3.3.7

Compare QOL and HRQOL of boys who lost ambulation
recently to those who lost ambulation longer ago
(Objective 6).

QOL and HRQOL scores of children who lost ambulation after 2012 were compared to
those who have lost ambulation before 2012 with Kruskal Wallis test.
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Figure 3-1 Schematic representation of measures of QOL and HRQOL

Single-item measure

Multidimensional measures

QOL

HRQOL

Specificity of HRQOL measure
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Table 3-1 Summary of child- and parent-reported QOL and HRQOL measures

Quality of My Life

Content of questionnaire

QOL or
HRQOL
measure

Single-item or
Generic or
Multidimensional disease specific
measure

Scoring

“overall, my life is…”

QOL

Single-item

“Considering my health, my
life is…”

HRQOL

Single-item

100 mm VAS
between ‘the worst’
and ‘the best’

Physical
Emotional, Social and
School
(make up the psychosocial
summary score)

HRQOL

Multidimensional Generic

HRQOL

Multidimensional Disease specific

How much a problem
has…been in the past
month, on a scale of
0-4. Items are reverse
transformed to score
out of 100, higer
score indicates higher
HRQOL
Same as above

HRQOL

Multidimensional Disease specific

Same as above

Generic

PedsQL 4.0 Generic
Core

23 items in total
PedsQL 3.0
Neurmuscular
module

About My/my child’s
neuromuscular disease ;
Communication ; About our
family resources
25 items in total

PedsQL Duchenne
Muscular
Dystrophy module

Daily activities ; Treatment
Barrier ; Worry;
Communication
18 items in total
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Table 3-2 Child and family factors tested in multivariable logistic regressions of
child or parent rating QOL to be much higher than HRQOL
Clinical factors

Demographic factors

- Age
- Fatigue level
- Presence of at least one mental or
developmental disorder (Yes/No)

- Parental education (no post-secondary
education; post-secondary education)
- Annual household income*
- Family Inventory of Life Events score

For categorical variables, the reference category is in bold and italicized
*Annual household income was treated as a continuous variable as it had 13 levels

Table 3-3 Child and family factors tested in multivariable regressions with
multidimensional HRQOL as outcomes
Clinical factors

Demographic factors

- Age
- Fatigue level
- Forced vital capacity
- Left ventricular ejection volume
- Use of steroid (Yes/No)
- Scoliosis (Yes/No)
- Presence of at least one mental or
developmental disorder (Yes/No)
- Wheelchair status (Never used,
intermittent use, permanent use)

- Parental education (high school or less;
vocational training; post-secondary
education)
- Annual household income*
- Family Inventory of Life Events score

For categorical variables, the reference category is in bold and italicized
*Annual household income was treated as a continuous variable as it had 13 levels
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Chapter 4
4

Results

This chapter presents results of the study corresponding to each objective. The initial
section describes the sample characteristics.

4.1 Sample Characteristics
From the Canadian Neuromuscular Disease Registry (CNDR), 176 eligible families were
identified. One child was excluded because his parent identified him as having epilepsy, a
significant co-morbidity, reducing the total number eligible to 175. Of these, 98 families
returned completed questionnaires, for a response rate of 56%. Eight families were lost to
follow-up due to incorrect addresses. Both parent and child completed questionnaires in
84 families, 13 families completed the parent questionnaire only and one family returned
the child questionnaire only.
The children’s clinical and demographic characteristics of are presented in Table 4.1. The
average age of the children [mean (SD)] was 10.5 (3.6) years. The majority (72%) of
children are ambulant. Over half had at least one mental or developmental disorder, with
developmental delay being the most common (23%).
Characteristics of the family are presented in Table 4.2. The majority of parents who
completed the questionnaire were mothers, and the mean age of the parent respondent
was 43 years. Over half of parent respondents who completed the questionnaire had postsecondary education, and the median household income was in the range of $75,000$99,000, which is around the national average (Government of Canada, 2013).

Non-respondents
Aggregate clinical characteristics of boys who did not respond were obtained from the
CNDR and are compared to those of respondents Table 4.1. Clinical characteristics of
non-respondents were not statistically significantly different from the respondents based
on these comparisons. However, the boys not in the study sample were older by one year,
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on average, and were slightly more likely to have lost ambulation, suggesting they may
be at a more severe stage of the disease.

4.2 Describe the QOL and HRQOL of boys with DMD in
Canada from both child and parent perspectives
(Objective 1).
Child self-report
On the QoML, the median QOL score, as reported by the boys, was 80.0, with a range of
37.8-100, the median HRQOL score was 77, and ranged from 0 to 100. As a reference,
the median QOL and HRQOL scores reported by children with rheumatoid arthritis were
93 and 89, respectively.
The child self-reported PedsQL 4.0 Generic Core, the PedsQL 3.0 Neuromuscular
Module and the PedsQL DMD Module mean scores, standard deviations and ranges are
presented in Table 4.3. As a reference, scores of healthy children and those with another
neuromuscular disorder, spinal muscular atrophy (SMA), which were obtained from
literature (Iannaccone et al., 2009; Varni et al., 2001), are also presented. Compared to
the healthy sample, the score of boys with DMD are lower in all domains of the PedsQL
4.0 Generic Core module, with largest difference in the physical domain, and the smallest
in the emotional domain. The PedsQL 4.0 Generic Core total and domain scores
comparing boys with DMD and children with SMA were very similar to one another. On
the PedsQL 3.0 Neuromuscular module, boys with DMD had higher mean score in
“About my neuromuscular disease’ domain, but a lower mean score in ‘Communication’
domain than children with SMA.

Parent proxy-report
On the QoML, the median QOL score of boys with DMD, as reported by their parents,
was 72, the scores ranged from 8 to 100. The median HRQOL score was 67, and ranged
from 16 to 100. As a reference, the median QOL and HRQOL scores reported by parents
of children with rheumatoid arthritis were 90 and 91, respectively (Gong et al., 2007).
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The parent proxy-reported PedsQL 4.0 Generic Core, the PedsQL 3.0 Neuromuscular
Module and the PedsQL DMD module mean scores, standard deviations and ranges are
reported in Table 4.4. As a reference, normative scores of healthy children and those with
spinal muscular atrophy, which were obtained from literature (Iannaccone et al., 2009;
Varni et al., 2001), were also presented. Compared to the healthy sample, the parentreported score of boys with DMD are lower in all domains of the PedsQL 4.0 Generic
Core module, the difference was largest in the physical domain, and smallest in the
emotional domain. Parents of boys with DMD rated their sons to have better physical
HRQOL, but worse psychosocial HRQOL than parents of children with SMA. On the
PedsQL 3.0 Neuromuscular module, parents of boys with DMD rated their sons to have
higher score in ‘About my neuromuscular disease’ and ‘About our family resources’
domains, but lower score in ‘Communication’ domain than parents of children with
SMA.

4.3 Examine the relationship between QOL and HRQOL
(Objective 2).
The relationship between single-item measures of QOL and HRQOL on the QoML were
examined with simple linear regression. On the child self-report, two boys rated their
QOL as 100 mm, and HRQOL as 0 mm. These extreme values were deemed as outliers
and removed from analysis. Better HRQOL was associated with better QOL
(QOL=0.45*HRQOL+44.25, p<0.0001). The adjusted R2 was 0.21. The single-item QOL
score did not correlate significantly with the multidimensional PedsQL 4.0 Generic Core
total score (r=0.17, p=0.17). The single-item HRQOL score was significantly correlated
with the PedsQL 4.0 Generic Core total score (r=0.30, p=0.01).
On the parent reported QoML, better HRQOL was associated with better QOL
(QOL=0.58*HRQOL+31.00, p<0.0001). The adjusted R2 was 0.44. The single-item
QOL score did not correlate with multidimensional PedsQL 4.0 Generic Core total score
(r=0.14, p=0.21). The single-item HRQOL score significantly correlated with the PedsQL
4.0 Generic Core total score (r=0.25, p=0.03).

46

4.4 Explore child and family characteristics that contribute
to any difference between QOL and HRQOL (Objective
3).
Multivariable logistic regressions were run to investigate what child and family
characteristics contributed to child and parent respondents rating QOL to be higher than
HRQOL. QOL was deemed to be higher than HRQOL if the difference between QOL
and HRQOL was in the top 25% of the sample. The factors that entered the logistic
regressions were: age of child, ambulation status, fatigue level, parent’s highest level of
education, total household income and FILE score.

Child self-report
The difference between QOL and HRQOL ranged from 100mm to -46.3mm, the median
difference was 0.8mm. QOL was deemed to be higher than HRQOL if it was 14.9 mm or
greater than HRQOL. None of the child or family characteristics tested was significantly
associated with a child respondent rating his QOL to be higher than HRQOL (Table 4.5).
However, children whose parents have post-secondary education were 5.7 times more
likely to rate their QOL to be much higher than HRQOL, with a very wide confidence
interval (CI: 0.7-237), due to the small sample size.

Parent proxy-report
The median difference between QOL and HRQOL was 0, and ranged from 55mm to 42.5mm. QOL was considered to be higher than HRQOL if it was 9.6mm or higher than
HRQOL. None the factors was significantly associated with an increased likelihood of a
parent rating their child’s QOL to be higher than HRQOL (Table 4.6). However, the lack
of significance could be due to the small sample size. For example, the odds ratio of
rating QOL to be higher is 4.5, comparing parents of ambulant boys to parents of nonambulant boys, the confidence interval is from 0.9 to 35.9. As with the child report one
factor associated with QOL being higher than HRQOL was parent education level,
parents who have post-secondary education were 2.0 times more likely to rate their son’s
QOL to be higher than HRQOL (CI: 0.6-7.4).
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4.5 Explore the association of clinical and demographic
characteristics with multidimensional measures of
HRQOL (Objective 4)
Regression analyses were carried out on the following HRQOL outcomes in child self
and parent proxy-reports: PedsQL 4.0 Generic Core total score, physical summary score,
psychosocial summary score, PedsQL 3.0 Neuromuscular Module total score and
PedsQL DMD Module total score. Bivariate regression analyses were conducted on each
of the explanatory variables and the HRQOL outcomes, and variables that had p-values
of less than 0.3 entered the maximum main effects models. The model selected was
backwards elimination, variables that had p-values of less than 0.1 stayed in the final
model. Two sets of analyses were run, one with FVC in the model, one without.
The child and family characteristics that remained in the final model had p-value less
than 0.10. The results of the regression models without and with FVC are presented
below (parameter estimate (SE)). The results of models without FVC are presented in
Tables 4.7 and 4.8. The assumptions of linear regression were met and the test for
collinearity was not significant. Results for each of the HRQOL outcomes in child selfreport are presented first, followed by parent proxy-report.

Child report
PedsQL 4.0 Generic Core Total Score
The factors that were significantly associated with the PedsQL 4.0 Generic Core total
score were fatigue, intermittent use and full-time use of wheelchair and parent’s highest
level of education. The R2 was 0.61. Children who reported less fatigue reported better
HRQOL (0.57(0.06)). Compared to children who did not use wheelchair, children who
used wheelchair intermittently (-7.47(2.36)) and who used a wheelchair full-time
(-15.14(2.46)) had significantly worse overall HRQOL. Compared to children whose
parent’s highest level of education was high school or less, children who have a parent
with college or university education had significantly better overall HRQOL (4.34(2.07)).
With FVC added to the model, the factors that remained significant in the final model
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were: fatigue (0.62(0.08)), intermittent wheelchair use (-8.53(3.03)) and full-time
wheelchair use (-13.11(3.00)). The R2 for this model was 0.64.
PedsQL Generic Core 4.0 Physical Summary Score
The factors that remained in the final model of the physical summary score were fatigue,
intermittent and full-time use of wheelchair. The R2 was 0.72. The children who reported
less fatigue had significantly higher physical summary score (0.46(0.09)). Children who
used wheelchair intermittently (-19.92(3.40)) and full-time (-42.41(3.48)) reported
significantly lower physical summary scores than children who did not use a wheelchair.
With FVC added to the model, the factors that remained significant in the final model
were: fatigue (0.47(0.12)), intermittent wheelchair use (-19.86(4.36)) and full-time
wheelchair use (-39.35(4.38)). The R2 for this model was 0.67.
PedsQL Generic Core 4.0 Psychosocial Summary score
The factors that were significantly associated with the Psychosocial Function score were
fatigue and annual household income. The R2 was 0.56. Less fatigue (0.68(0.07)) and
higher household income (1.14(0.46)) were associated with better psychosocial HRQOL.
FVC did not meet the criteria to enter the maximum model.
PedsQL Neuromuscular Module 3.0 Total Score
The factors that remained in the final model for the Neuromuscular module total score
were: age, fatigue, household income and full-time use of wheelchair. The R2 was 0.76.
Older children (0.57(0.27)), those with less fatigue (0.74(0.05)) and higher household
income (0.55(0.31)) reported better HRQOL on the Neuromuscular module. Compared to
boys who did not use wheelchairs, those who use wheelchair full-time (-12.45(2.25))
reported worse HRQOL. With FVC added to the model, the factors that were significant
were fatigue (0.70(0.07)), full-time use of wheelchair (-8.91(2.26)) and total household
income (0.80(0.42)). The R2 was 0.72.
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PedsQL DMD Module Total Score
The factors that remained in the final model of PedsQL DMD module total score were
fatigue, FILE score, total household income and full-time use of wheelchair. The R2 was
0.60. The boys who reported less fatigue 0.88((0.09)), whose family had higher FILE
score (more stresses) (0.01(0.006)) and higher household income (0.98(0.08)) had
significantly better HRQOL on the DMD module. Boys who use wheelchair full-time (14.3(2.90)) had significantly worse HRQOL than boys not in wheelchair. With FVC
added to the model, the factors that remained in the final were fatigue (0.71(0.09)) and
FVC (0.40(0.08)). The R2 was 0.65.

Parent report
PedsQL 4.0 Generic Core Total score
The factors that remained in the final model were fatigue, intermittent use of wheelchair,
full-time use of wheelchair, and parent’s highest level of education. The R2 was 0.48.
Parents who reported their children to have less fatigue (higher score) also reported better
HRQOL (0.53(0.08) for their children on the PedsQL Generic Core module. Compared to
parents of children who did not use a wheelchair, parents of children who use a
wheelchair intermittently (-9.60(2.9)) or full-time (-8.49(3.2)) reported significantly
worse HRQOL for their children. Parents who had post-secondary education reported
significantly higher HRQOL (6.77(2.6)) compared to parents whose highest level of
education was high school education or less. With FVC added to the model, the factors
that remained significant in the final model were: fatigue (0.51(0.10)), intermittent
wheelchair use (-9.70(3.68)), full-time wheelchair use (-7.07(3.92)) and parent having
post-secondary education (5.57(3.25)). The R2 for this model was 0.44.
PedsQL Generic Core 4.0 Physical Summary Score
The factors that remained in the final model of the physical summary score were fatigue,
intermittent use of wheelchair, full-time use of wheelchair, and parent’s highest level of
education. The R2 was 0.25. Parents who reported their children as having less fatigue
(0.37(0.2)) also reported better physical summary score for their children. Compared to
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parents of children who did not use a wheelchair, parents of children who used a
wheelchair intermittently (-15.07(5.5)) or full-time (-18.90(6.0)) reported significantly
better HRQOL for their children. Parents who had post-secondary education reported
significantly better HRQOL for their children (11.54(4.8)) compared to parents whose
highest level of education was high school education or less. With FVC added to the
model, the factors that remained significant in the final model were: fatigue (0.34(0.18)),
intermittent wheelchair use (-19.27(6.89)) and full-time wheelchair use (-19.94(7.41)).
The R2 for this model was 0.18.
PedsQL Generic Core 4.0 Psychosocial Summary Score
The factors that remained in the final model of the psychosocial summary score were age,
intermittent use of wheelchair, fatigue, household income, and having at least one
developmental or mental disorder. The R2 was 0.53. Parents whose children were
younger (-0.73(0.3)), who reported their children to have less fatigue (0.58(0.08)) and
those with a higher household income (0.81(0.5)), reported better psychosocial summary
score for their children. Compared to parents of children who do not have any
developmental or mental disorder, parents of children who have at least one disorder
reported significantly worse HRQOL (-4.50(2.5) for their children. Compared to parents
of children who did not use a wheelchair, parents of children who used a wheelchair
intermittently (-4.70(2.6)) reported significantly worse HRQOL. With FVC added to the
model, the factors that remained in the final model were fatigue (0.58(0.08), intermittent
use of wheelchair (-6.35(2.9)) and parent whose highest level of education is vocational
training (9.24(4.4)) or post-secondary education (9.88(3.7)) compared to high school
education. The R2 was 0.53.
PedsQL Neuromuscular Module 3.0 Total Score
The factors that remained in the final model of Neuromuscular 3.0 module total score
were fatigue, full-time wheelchair use, and the FILE score. The R2 was 0.70. Parents who
reported their children to have less fatigue (0.62(2.37)) and lower FILE score (less stress)
(-0.01(0.004)) also reported better HRQOL on the neuromuscular module. Compared to
parents of children who did not use a wheelchair, parents of children who used a
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wheelchair full-time (-15.6(2.38)) reported significantly worse HRQOL. With FVC
added to the model, the factors that remained in the final model were fatigue (0.72(0.07)),
intermittent use of wheelchair (-5.88(2.9)) and full-time use of a wheelchair (-16.9(3.03)).
The R2 for this model was 0.73.
PedsQL 3.0 DMD Module Total Score
The factors that remained in the final model of the DMD module total score were fatigue,
full-time wheelchair use, and household income. The R2 was 0.66. Parents who reported
their children to have less fatigue (0.70(0.07)) and who had higher household income
(1.27(0.5)) reported higher DMD module score. Compared to parents of children who did
not use a wheelchair, parents of children who used a wheelchair full-time (-15.45(2.8))
reported significantly worse HRQOL for their children. In the group with FVC in the
model, the factors that remained in the final model were age (-1.19(0.5)), fatigue
(0.78(0.08)), FVC (0.25(0.08)), intermittent wheelchair use (6.01(3.1)), and household
income (1.09(0.60)). The R2 for this model was 0.74.

Summary of regression analyses
The factors most consistently associated with HRQOL outcomes were level of fatigue
and wheelchair use. Fatigue level was significantly associated with every HRQOL
outcome for both child and parent reports, and in greater magnitude than other variables.
The use of a wheelchair was associated with all HRQOL outcomes except for childreported PedsQL Generic Core psychosocial score. In both parent and child reports,
parent’s highest level of education were significantly associated with the PedsQL Generic
Core total score. For both child and parent report, FVC remained in the final model of the
DMD module total score.

4.6 Compare QOL and HRQOL of ambulant boys who were
diagnosed recently to those who were diagnosed longer
ago (Objective 5).
The mean age of boys diagnosed after 2012 was 5.8, of those diagnosed before 2012 was
9.5. The mean self-reported and parent-reported scores of boys diagnosed since 2012
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(N=5) were compared against those who were diagnosed before 2012 (N=51) but were
still ambulant are presented in Table 4.9. Wilcoxon rank sum test was carried out, and no
significant differences were found in any of the scores.

4.7 Compare QOL and HRQOL of boys who lost
ambulation recently to those who lost ambulation longer
ago (Objective 6).
The mean self-reported and parent-reported scores of boys who lost ambulation after
2012 (N=3) were compared to those who lost ambulation before 2012 (N=20) are
presented in Table 4.10. Wilcoxon rank sum test was carried out, no significant
differences were found in any of the scores.
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Table 4-1 Demographic and clinical characteristics of respondent and nonrespondent boys with DMD
Variables
Age (years, SD)

Respondents
N=98
10.7 (3.7)

Non-respondents
N=77
11.7 (3.2)

Ambulant (%)

72.4

64.0

Wheelchair use: intermittent

25.5

31.0

full-time
Currently receiving steroid (%)

23.5
80.6

25.0
85.7

Scoliosis (%): surgically corrected

4.0

Not available

Not surgically corrected
Cardiomyopathy (%)

8.1
5.1

6.4

Receive non-invasive ventilation (%)

6.1

2.1

78.8 (17.7)

80.5

64.7 (7.2)

62.4

2*

-

Last FVC mean (SD)
(n=67)
LVEF mean (SD)
(n=72)
Co-morbidities
Developmental or mental disorder
(%)
Developmental delay
Learning disorder
Attention deficit disorder
Autism spectrum disorder
Oppositional defiant disorder
Conduct disorder
Depresion
Anxiety
Have at least one developmental or
mental disorder

Participation in clinical trial(%)

22.4
28.6
16.3
10.2
2.0
0
5.1
14.3
55.1

28.6

-

*2 boys had asthma, they were kept in the sample as asthma could be a consequence of
pulmonary function decline

54

Table 4-2 Characteristics of respondent families
Variables
Age of parent respondent (years, SD)

Respondents
N=98
42.7 (7.0)

Biological parent (%)

91.8

Female (%)

72.0

Married (%)

80.6

Living with spouse or partner

87.8

Mean household size

3.0

Parent’s highest level of education (%)
High school or less
Vocational
College/university
Choose not to answer
Parent’s work status
Not working
Working
Homemaker
Household income (%)
<$25,000
$25,000 - $50,000
$50,000-$74,999
$75,000 - $99, 999
$100,000 –$149,999
≥$150, 000
Don’t know
Family Inventory of Life Events score (Mean, SD)

18.3
15.3
61.2
4.1
20.4
61.2
16.3
12.2
18.4
9.2
16.3
16.3
19.3
6.1
314.3 (260.1)
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Table 4-3 Mean self-reported PedsQL Generic Core, Neuromuscular and DMD
module scores in boys with DMD, children with spinal muscular atrophy and
healthy children
Boys with DMD
N
Generic Core Total
score
Physical
summary score
Psychosocial
summary score
Emotional

82
82
83
83

Social

83

School

81

Neuromuscular
module Total
Score
About my
Neuromuscular
disease
Communication

83

About our family
resources

64

DMD Total Score

64

Daily activities

64

Treatment

64

Worries

64

Communication

64

Mean (SD)
[range]
58.3 (15.5)
[25.0-97.8]
45.3 (23.8)
[3.1-100]
65.4 (15.5)
[31.7-96.7]
66.4 (21.5)
[20.0-100]
63.3 (18.3)
[20.0-100]
66.7 (19.4)
[20.0-100]
72.0 (13.5)
[37.0-97.0]

Spinal Muscular Atrophy
(Iannaccone et al., 2009)

Healthy
(Varni et al., 2001)

N
125

Mean (SD)
58.7 (14.4)

N
401

Mean (SD)
83.0 (14.8)

123

43.4 (21.1)

400

84.4 (17.3)

125

66.6 (16.3)

399

82.4 (15.5)

125

67.0 (23.0)

400

80.9 (19.6)

125

66.1 (19.5)

399

87.4 (17.2)

124

66.2 (20.9)

386

78.6 (20.5)

123

67.5 (15.6)

-

-

82

71.7 (13.9)
[38.2-98.4]

123

65.9 (16.5)

-

-

64

63.9 (26.4)
[37.0-97.0]
74.9 (20.1)
[20.0-100]

80

70.8 (23.6)

-

-

80

74.7 (22.2)

-

-

66.6 (17.8)
[26.3-100]
64.6 (25.0)
[15.0-100]
72.6 (24.2)
[6.3-100]
65.4 (21.9)
[16.7-100]
63.1 (28.3)
[0-100]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-
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Table 4-4 Mean parent reported PedsQL Generic Core, Neuromuscular and DMD
module scores in boys with DMD, children with spinal muscular atrophy and
healthy children
Parent report

Boys with DMD
N

Generic Core Total
Score
Physical
summary score
Psychosocial
summary score
Emotional domain

95
95
95
95

Social domain

95

School domain

95

Neuromuscular
Module Total Score
About my
Neuromuscular
disease
Communication

96

About our family
resources
DMD Module Total
Score
Daily activities

96

96

96

97
97

Treatment

96

Worries

97

Communication

93

Mean (SD)
[range]
51. 9 (16.5)
[21.7-93.5]
42.8 (25.7)
[0-96.9]
57.2 (15.7)
[28.3-95]
62.2 (18.0)
[15.0-100]
50.0 (20.0)
[8.3-100]
58.7 (19.5)
[25.0-100]
67.3 (17.0)
[25.0-97]
69.2 (17.3)
[23.5-100]
58.0 (28.6)
[0-100]
66.7 (23.9)
[26.3-100]
61.5 (18.8)
[13.9-95.8]
56.3 (25.5)
[0-100]
70.8 (23.5)
[6.3-100]
60.7 (24.7)
[0-100]
58.9 (30.2)
[0-100]

Spinal Muscular Atrophy
(Iannaccone et al., 2009)

Healthy
(Varni et al., 2001)

N
174

Mean (SD)
53.4 (14.2)

N
717

Mean (SD)
87.6 (12.3)

172

36.3 (24.6)

717

89.3 (16.4)

174

74.8 (18.2)

717

86.6 (12.8)

173

62.2 (17.6)

718

82.6 (17.5)

174

57.4 (17.4)

716

91.6 (14.2)

154

63.8 (20.0)

611

85.5 (17.6)

172

59.7 (16.8)

-

-

176

58.8 (17.7)

-

-

172

67.0 (31.1)

-

-

176

59.6(22.2)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-
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Table 4-5 Results of multivariable logistic regression of rating QOL to be much
higher HRQOL on child-reported QoML (N=64).
Parameter

Odds Ratio

95% Confidence Limits

Ambulation

0.6

0.1 - 3.2

Household income

1.0

0.8 - 1.5

Age

1.1

0.8 - 1.4

Parent’s highest level of education
(post-secondary v.s. not)

5.7

0.7 - 237

Presence of at least one developmental
Or mental disorder

0.7

0.1- 2.9

Fatigue score

0.7

0.4 - 1.0

FILE score

0.9

0.7 - 1.0

QOL was considered to be much higher than HRQOL if QOL was 14.9 mm or greater than
HRQOL on the VAS (in the top 25%).
Fatigue score: higher fatigue score indicates less fatigue, score was divided by 10 to reflect a
more meaninful level of change. The odds ratio is that of child with DMD rating his QOL to be
much higher than HRQOL for every 10 unit of increase in fatigue score.
FILE: higher FILE score indicates higher level of family stress experienced in the past year. Score
was divided by 50 to reflect a meaningful level of change. Odds ratio represents odds ratio of
child with DMD rating his QOL to be much higher than HRQOL for every 50 unit of increase in
FILE score
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Table 4-6 Results of logistic regression for rating QOL to be much higher than
HRQOL on parent-reported QoML (N=74).
Parameter

Odds Ratio

95% Confidence Limits

Ambulation

5.3

0.8 - 35.9

Household income

0.9

0.8 - 1.1

Age

1.0

0.8 - 1.2

Parent’s highest level of education
(post-secondary v.s. not)

2.0

0.6 - 7.4

Presence of at least one developmental
Or mental disorder

0.6

0.1 - 1.3

Fatigue score

0.7

0.5 - 1.0

FILE score

1.0

0.9 - 1.1

QOL was considered to be much higher than HRQOL if QOL was 9.4 mm or greater than HRQOL
on the VAS (in the top 25%).
Fatigue score: higher fatigue score indicates less fatigue, score was divided by 10 to reflect a
meaninful level of change. The odds ratio is that of parent who rated their child’s QOL to be much
higher than HRQOL for every 10 unit of increase in fatigue score.
FILE : higher score indicates higher level of family stress experienced in the past year. Score was
divided by 50 to reflect a meaningful level of change. Odds ratio is that of parent who rated child
with DMD’s QOL to be much higher than HRQOL for every 50 unit of increase in FILE score
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Table 4-7 Results of backwards elimination models of child and family factors on various
child-reported PedsQL measures.

Age
Fatigue
FILE score

PedsQL 4.0
Generic
Core Total
(N=69)

PedsQL 4.0
Generic Core
Physical
(N=71)

PedsQL 4.0
Generic Core
Psychosocial
(N=79)

PedsQL 3.0
Neuromuscular
Total
(N=75)

PedsQL
DMD Total

N.S.

N.S.

N.S.

0.57 (0.3)

N.S.

0.57
(<0.0001)

0.46 (<0.0001)

0.67 (<0.0001)

0.74 (<0.0001)

N.S.

N.S.

N.S.

N.S.

0.88
(<0.0001)
0.011
(0.006)

N.S.

N.S.

1.14 (0.02)

0.55 (0.06)

N.S.

---

---

---

---

-7.47
(0.002)

-19.92
(<0.0001)

N.S.

N.S.

-15.14
(<0.0001)

-42.41
(<0.0001)

-12.4
(0.0004)

-14.51
(<0.0001)

N.S.

N.S.

N.S.

N.S.

N.S.

N.S.

N.S.

N.S.

Did not enter
maximum model

Did not enter
maximum
model

---

Did not enter
maximum
model

Did not enter
maximum
model

Did not enter
maximum model

Did not enter
maximum
model

(N=59)

Household income

Wheelchair
Never (ref.)
Intermittent

Full-time

Steroid
≥1 developmental
or mental disorder
Parental education
≤ High school
(ref.)
Vocational
Post-secondary

N.S.

Did not enter
maximum
model

4.34 (0.04)

FVC was not included in models to maximize sample sizes
Parameter estimate and p-value of factors that remained significant (p<0.10) in the final model after backwards
elimination are presented
N.S. - Not significant after backwards elimination;
The variables scoliosis and LVEF did not meet criteria to enter maximum model for any of the HRQOL outcomes,
they are not presented in the table. Binary variables (coded as Yes/No) are steroid and presence of at least one
developmental or mental disorder, the reference group is “No”. Multilevel categorical variables are wheelchair
status and parental education, the reference category is indicated as ‘ref.’ Parameter estimates in continuous
variables indicates amount of change in HRQOL for one unit change in the explanatory variables.
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Table 4-8 Results of backwards elimination models of child and family factors on various
parent-reported PedsQL measures.
PedsQL 4.0
PedsQL 4.0
PedsQL 4.0
PedsQL 3.0
PedsQL
Generic
Generic Core Generic Core Neuromuscular DMD Total
Core Total
Physical
Psychosocial
Total
(N=85)
(N=85)
(N=85)
(N=88)
(N=90)
N.S.

N.S.

-0.73 (0.030)

0.53
(<0.0001)

0.37 (0.02)

0.57 (<0.0001)

FILE score

N.S.

N.S.

N.S.

Did not enter
maximum model

N.S.

Total household
income

N.S.

N.S.

0.82

N.S.

1.27 (0.011)

---

---

---

---

---

Intermittent

-9.60 (0.0099)

-16.27 (0.007)

-4.7 (0.08)

N.S.

N.S.

Full-time

-8.49 (0.0101)

-19.94 (0.002)

N.S.

-15.6 (<0.0001)

-16.10
(<0.0001)

N.S.

Did not enter
maximum
model

N.S.

Did not enter
maximum model

Did not enter
maximum
model

N.S.

N.S.

-4.46 (0.074)

N.S.

N.S.

Did not enter
maximum model

Did not enter
maximum
model

Age
Fatigue

Wheelchair
Never (ref.)

Scoliosis
≥1 developmental
or mental disorder

Parental
education
≤ High school
(ref.)
Vocational

---

---

---

N.S.

N.S.

N.S.

Post-secondary

6.78 (0.010)

11.54 (0.02)

N.S.

0.62
0.62 (<0.0001)

N.S.

0.7 (<0.0001)

FVC was not included in models to maximize sample sizes.
Parameter estimate and standard error of factors that remained significant (p<0.10) in the final model after
backwards elimination are presented.
N.S. - Not significant after backwards elimination
The variables steroid and LVEF did not meet criteria to enter maximum model for any of the HRQOL outcomes,
they are not presented in the table.
Binary variables (coded as Yes/No) are steroid, scoliosis and presence of at least one developmental or mental
disorder, the reference group is “No”. Multilevel categorical variables are wheelchair status and parental
education, the reference category is indicated as ‘ref.’. Parameter estimates in continuous variables indicates
amount of change in HRQOL for one unit change in the explainatory variabels.
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Table 4-9 QoML and PedsQL 4.0 Generic Core scores of ambulatory boys who were
diagnosed recently and those who have been diagnosed for longer a period
Diagnosed after 2012
Diagnosed before 2012
(N=5)

(N=51)

QoML Overall

80.9 (24.1)

79.8 (18.1)

QoML Health

75.3 (31.2)

76.4 (20.8)

PedsQL Generic Core Total

69.7 (7.3)

60.0 (14.6)

PedsQL Generic Core

65.6 (7.0)

51.4 (20.5)

72.1 (12.0)

64.6 (14.9)

81.42 (4.92)

73.2 (11.7)

QoML Overall

76.1 (13.9) n=2

69.9 (18.6)

QoML Health

76.8 (16.4)

67.9 (21.5)

PedsQL Generic Core Total

54.6 (13.2)

54.3 (16.4)

PedsQL Generic Core

40.8 (18.0)

47.5 (23.3)

63.8 (11.1)

57.9 (15.4)

PedsQL Neuromuscular

77.3 (12.9)

72.5 (13.2)

PedsQL DMD

66.4 (16.7)

67.1 (15.9)

Child report

Physical
PedsQL Generic Core
Psychosocial
PedsQL Neuromuscular
Parent report

Physical
PedsQL Generic Core
Psychosocial
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Table 4-10 QoML and PedsQL Generic Core 4.0 scores of non-ambulatory boys
who lost ambulation recently and those who have been non-ambulant for a longer
period
Lost ambulation after 2012 Lost ambulation before2012
(N=3)

(N=20)

QoML Overall

69.3 (26.8)

80.12 (18.3)

QoML Health

51.0 (40.3)

69.07 (25.6)

PedsQL Generic Core Total

35.5 (6.7)

52.19 (14.2)

PedsQL Generic Core

11.5 (9.3)

25.24 (19.6)

48.3 (9.3)

66.88 (17.3)

PedsQL Neuromuscular

50.0 (17.4)

73.24 (11.7)

PedsQL DMD

48.6 (23.2)

62.01 (20.4)

QoML overall

46. 4 (34.9)

71.79 (16.7)

QoML health

40.7 (17.8)

72.89 (17.6)

PedsQL generic core total

35.9 (15.3)

45.59 (14.3)

PedsQL generic core

31.3 (43.3)

32.31 (30.1)

38.3 (9.3)

54.09 (16.1)

PedsQL Neuromuscular

37.3 (6.8)

53.63 (16.1)

PedsQL DMD

35.2 (15.3)

48.32 (19.9)

Child report

Physical
PedsQL Generic Core
Psychosocial

Parent report

physical
PedsQL generic core
psychosocial
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Chapter 5
5

Discussion

This chapter will provide interpretations of study findings and place them in the context
of existing literature. Clinical and research implications of some results, as well as the
strengths and limitations of the study are discussed. Finally, conclusions and potential
future research avenues are presented.

5.1 Summary of Results
5.1.1

Describe the QOL and HRQOL of boys with DMD in Canada
from both child and parent perspectives (Objective 1).

When compared to children with rheumatoid arthritis and their parents, respectively,
those with DMD and their parents reported poorer QOL and HRQOL (Feldman et al.,
2000). This was to be expected given DMD is a life limiting disease whereas rheumatoid
arthritis is not usually viewed in that manner. For both DMD and rheumatoid
populations, parents’ ratings were lower than children’s self-assessment, this difference
was more pronounced in the DMD population in this study.
Three measures from the PedsQL Inventory were used as multidimensional measures of
HRQOL. The results in our sample were similar to those reported by others (McDonald
et al., 2010; Uzark et al., 2012). From the generic measure, HRQOL was worse in boys
with DMD than healthy children. The biggest difference was found in the physical
domain. This is not surprising considering the hallmark of the disease is progressive
muscle loss. This was also found to be the case by other studies (Baiardini et al., 2011;
Bendixen et al., 2012; Bray et al., 2011; Davis et al., 2010; Elsenbruch et al., 2013;
McDonald et al., 2010; Opstal et al., 2013; Uzark et al., 2012). Within the psychosocial
summary in the Generic Core module, the social domain was the most impacted, this was
also in line with findings of other authors (Bendixen et al., 2012; Elsenbruch et al., 2013;
Hu et al., 2013; Uzark et al., 2012). Furthermore, the social domain was also the only one
out of the psychosocial domains that fell below the significantly impaired cut-off score,
which was designated as one standard deviation below the population mean (Varni et al.,
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2003). It is likely that diminished social HRQOL in boys with DMD is partially due to
their physical limitations, but social function could also be a reflection of the high level
of cognitive deficits in this population, impacting the boys’ ability to communicate with
others of similar age.
Across all measures QOL and HRQOL, parents’ ratings tended to be lower than boys’
self-reports, which has been consistently observed across a number of paediatric chronic
illnesses (Ingerski et al., 2010; Upton et al., 2008). There could be a number of
explanations for this observation: children likely do not understand the long term
implications of their disease to the same extent their parents do, may have adjusted to
their disorder over time, or may have different concerns than their parents when it comes
to factors that influence HRQOL or QOL. Parents may also let their own worries and fear
about their child’s disease influence their assessment of their child’s HRQOL.
Spinal muscular atrophy (SMA) is another type of paediatric neuromuscular illness, and
is a good comparison group for DMD. Like DMD, SMA is characterized by progressive
muscle weakness, however, muscular degeneration occurs at an earlier age and much
more severely. On the other hand, children with SMA are not affected cognitively to the
extent of boys with DMD. On the PedsQL 3.0 Neuromuscular module, both boys with
DMD and their parents reported higher scores in “About my neuromuscular disease”
domain, but lower scores in the “Communication” domain than children with SMA and
their parents. This is consistent with the symptomology of the two diseases, there is a
higher prevalence of cognitive disability in DMD which could further impact the boys’
ability to communicate and socialize with others (Cotton et al., 2001). Children with
SMA are not impacted cognitively but have more severe physical symptoms (Iannaccone
et al., 2009). In our sample, 51% of parents indicated their child with DMD has a
developmental delay and/or learning disorder, and 10% of parents indicated their child
has autism spectrum disorder, all of which could have a negative influence on the child’s
communication skills. However, it should be noted that we did not directly measure the
cognitive ability of our sample, and any relationship between cognitive ability and
HRQOL is speculative.
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Lastly, the more disease-specific PedsQL 3.0 Neuromuscular module was better at
discriminating between boys with DMD and children with SMA than the Generic Core
module, as the differences between the two groups were more pronounced on the
Neuromuscular module than Generic Core module. This was to be expected for diseasespecific measures (Eiser & Morse, 2001a; Quittner et al., 2003), which are designed to be
more sensitive to differences within a disease group.

5.1.2

Examine the relationship between QOL and HRQOL
(Objective 2).

Single-item measures of QOL and HRQOL were rated as distinct but related concepts by
both the boys with DMD and their parents. This was also found to be the case by
Feldman et al. (2000), who found that in a group of children with rheumatoid arthritis,
HRQOL explained 30% of the variability in QOL. In our sample, HRQOL explained
21% and 44% of the variability in QOL in child- and parent-reported measures,
respectively. Our results supported our hypothesis that boys with DMD and their parents
consider QOL and HRQOL to be distinct but related concepts. QOL and HRQOL were
significantly related to each other, but for both child and parent reports, over 50% of the
variability in QOL were not explained by HRQOL. It is also likely that the association
between these two single-item measures of QOL and HRQOL is partially due to
common-method variance, specifically because of common scale format and anchoring
(Snow et al., 2013). Thus, to further investigate the relationship between QOL and
HRQOL, we also tested the association between the single-item QOL and a
multidimensional HRQOL, the PedsQL 4.0 Generic Core module, and found that they
were not significantly related to one another. However the lack of association between
these two measures could be due to differences in their design - QOL is a single-item
measure whereas the PedsQL 4.0 Generic Core module is a multidimensional measure.
We investigated the relationship between two measures of HRQOL (one single-item and
one multidimensional), and found they were significantly associated with one another. It
appears that when asked to ‘consider their health’ on the QoML, boys with DMD and
their parents considered aspects of the child’s life that are more or less aligned with
domains measured by the multidimensional HRQOL. Whereas, when the respondents are
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rating the broader, overall QOL, they may be thinking less about their health, or were
considering aspects of their lives other than health-related domains. This theory is also
supported by our and Feldman’s finding that HRQOL explained less than 50% of the
variability in QOL.
In the qualitative debriefing that took place during the development of the QoML, factors
such as relationship with family and friends were identified, in addition to health, as
being important in determining overall QOL (Feldman et al., 2000). People place
different values on various aspects of their health and life, leading to different
assessments of QOL in relation to HRQOL. Those lacking in health may have other
aspects of their lives that ‘make up’ for that health deficit. Our results support the notion
that QOL and HRQOL are regarded as related constructs by boys with DMD and their
parents, and suggest there are factors outside of HRQOL that contribute to QOL.

5.1.3

Explore child and family characteristics that contribute to any
difference between QOL and HRQOL (Objective 3).

On the QoML questionnaire, QOL and HRQOL were both measured on VAS scales. We
explored factors that were associated with the difference between single-item measures of
QOL and HRQOL. More specifically, we investigated child and family characteristics
that could potentially contribute to boys with DMD and their parents rating QOL to be
higher than HRQOL.
For both child self and parent proxy-reports, no factors were found to be significantly
associated with a respondent rating their QOL to be higher than HRQOL. However, the
lack of significance is likely due lack of statistical power given the small sample size. By
child report, children whose parents had post-secondary education were 5.2 times more
likely to rate their QOL to be much higher than children whose parents did not have postsecondary education, even though the relationship was not significant. Parental education
has been found to be a factor significantly associated with child’s HRQOL in a group of
children with sickle cell disease (Panepinto et al., 2005).
We divided our sample into two groups: those who rated QOL to be much higher than
HRQOL and those who did not. In the latter group, the heterogeneity is greater as we
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grouped those who rated QOL to be slightly higher than, equal to, and lower than
HRQOL together. The extent of heterogeneity could have reduced the power and
contributed to the wide confidence intervals.

5.1.4

Explore the association of child and family characteristics
with multidimensional measures HRQOL (Objective 4).

We explored child and family factors associated with multidimensional measure of
HRQOL from the PedsQL Inventory. Due to the exploratory nature of our study, we did
not anticipate any specific factor as a primary predictor of interest. Instead we used
backwards elimination to elucidate a subset of variables that are associated with HRQOL
which could inform future research. By both child and parent reports, the factor that was
consistently associated with HRQOL was fatigue. Fatigue was associated with every
HRQOL outcome, and in greater magnitude than other factors; boys and parents who
reported greater fatigue reported worse HRQOL. Fatigue has not been examined closely
in the DMD population, as far as we could determine from the literature. Thus, the strong
relationship between fatigue and HRQOL came as an unexpected, but not an overly
finding.
Muscle fatigue is a physiological consequence of muscle degradation in DMD; decreased
lung and heart function all could contribute to weakness and fatigued muscles (Angelini
& Tasca, 2012). Fatigue can also be thought of as a subjective experience and measured
as such. The PedsQL 3.0 Multidimensional Fatigue module was initially designed to
measure fatigue in paediatric cancer patients and was found to be feasible, reliable and
valid (Varni et al., 2002). It has also been validated in a variety of other chronic illnesses
(Huang et al., 2013; Marcus et al., 2009; Meeske et al., 2004; Varni et al., 2004). Fatigue
manifests itself both physically and mentally, and is multidimensional in nature. A
confirmatory factor analysis supported the existence of three domains in the PedsQL 3.0
Multidimensional Fatigue Scale: the general, sleep/rest and cognitive domains (Varni et
al., 2013).
Other studies have also reported associations between fatigue and poorer QOL or
HRQOL in children with chronic illnesses. In a group of paediatric cancer survivors,
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fatigue was the only factor significantly associated with both physical and psychological
HRQOL (Meeske et al., 2007). Fatigue has consistently been identified as an important,
if not the most important factor associated with HRQOL (Eddy & Cruz, 2007; Huang et
al., 2013) in children with various chronic illnesses.
Fatigue in neuromuscular disorders has been mostly studied in adults, and samples have,
to our knowledge, not included DMD patients. Fatigue is a common complaint of adult
patients with neuromuscular illnesses, it was reported by 60% of a cross-sectional sample
of adults with common neuromuscular disorders (Kalkman et al., 2005). In other studies
of adults with neuromuscular illness, fatigue was one of the factors associated with
HRQOL (Burns et al., 2012; Oksuz et al., 2009). In a study of people with muscular
dystrophies, pain and fatigue were found to be independently associated with lower
physical function and greater depression (Alschuler et al., 2012).
Because fatigue is such a common manifestation in neuromuscular illnesses, some
neuromuscular disease-specific HRQOL measures contain a fatigue-related component.
For example, the Individualized Neuromuscular QoL questionnaire for adults has a
fatigue domain (Rose et al., 2012). In our study, it was noted that the PedsQL of fatigue
module and the PedsQL Neuromuscular module share two of the questions, which
renders them not completely independent from each other. However, given the strong
significance in every other module, where there were no identical questions, we believe
this is a robust finding. We also examined whether there were any associations between
fatigue and other clinical variables. By parent proxy-report, there were no significant
associations between fatigue and any of the clinical variables such as age and FVC. In
contrast, by child report, children who were using a wheelchair intermittent had
significantly greater fatigue than children not using a wheelchair. Perhaps boys who are
just transitioning into wheelchair use struggle with trying to maintain ambulation when
they maybe too weak to do so. This is a well-recognized clinical issue often resulting in
pain and falls. Taken together, fatigue was clearly a significant factor negatively
impacting HRQOL of boys with DMD, and this is an important novel finding which
potentially contributes to advancing research and improving clinical care for DMD
patients.

69

Another factor consistently associated with HRQOL was wheelchair use. Boys who were
in wheelchairs, had poorer HRQOL than boys not in wheelchairs across all HRQOL
measures, with the exception of psychosocial summary score. The negative disease
milestone of transition to full time wheelchair use is of particular focus to boys, their
families and clinicians and so this finding is not surprising in the clinical context. This
result is similar to other studies that found significant associations between clinical
measures of strength and physical HRQOL, but not psychosocial HRQOL (Bray et al.,
2010, 2011; McDonald et al., 2010). These results suggest that while progression of
DMD severely impacts physical aspects of a child’s life, it does not necessarily impact
the emotional aspects of a child’s life, at least, not to the same degree as the physical
aspect.
Age was only associated with the PedsQL 3.0 Neuromuscular module, and no other
HRQOL measures. This was a somewhat surprising result as age is often considered a
proxy for disease severity and one would speculate that it would be associated with
HRQOL. The fact that age did not remain significantly associated with most measures of
HRQOL could be the result of adjusting for other factors such as wheelchair usage. In
unadjusted analyses, by parent proxy-report, age was related to all measures of HRQOL;
by child report, age was related to PedsQL 4.0 Generic core total and physical summary
score, and the Neuromuscular module score. In other studies (Davis et al., 2010; Uzark et
al., 2012), older boys with DMD had poorer physical HRQOL than younger boys, but not
worse psychosocial HRQOL.
Having at least one developmental or mental disorder was negatively associated with
parents’ report of their child’s psychosocial HRQOL is consistent with other literature
(Panepinto et al., 2005). A study of children with epilepsy also found that presence of
cognitive problems was predictive of poorer HRQOL (Speechley et al., 2012).
FVC appears to be a significant factor only in the PedsQL 3.0 DMD module is consistent
with the physical manifestation of the disease. Loss of respiratory function is an
important aspect of DMD, and its association with the DMD module highlights the
sensitivity of the PedsQL 3.0 DMD module to the disease itself.
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Due to the exploratory nature of our study, we used multivariable regressions where all
the explanatory factors were treated as equals. Alternatively, structural equation
modelling, and more specifically, path analysis, would allow us to investigate the
relationship between the explanatory variables in a more sophisticated manner and
potentially establish a more causal relationship between these variables and the outcome.
For example, a potential path could be that FVC or ambulation status affects fatigue
level, which in turn affects HRQOL.

5.1.5

Compare QOL and HRQOL of ambulant boys who were
diagnosed recently to those who were diagnosed longer ago
(Objective 5).

We compared HRQOL of boys who were diagnosed more recently (after 2012) with
those who had been diagnosed for longer (before 2012) but who were at the same plateau
phase of the disease (i.e. who were still ambulant). During this phase, the health condition
of these boys stays relatively constant. Thus we hypothesized that boys who were
diagnosed more recently and their parents would report worse HRQOL than boys who
have been diagnosed for longer who have had more to time to adjust to the diagnosis.
This was not what we found. Within the ambulatory group, there were no differences in
any of the HRQOL outcomes between boys who were diagnosed after 2012 and boys
who had been diagnosed for longer. This did not support our hypothesis that the boys
more recently diagnosed would have worse HRQOL, even on the psychosocial HRQOL.
The fact our results did not support our hypothesis was not as surprising in child-report as
it is for parent proxy reports. When these boys were diagnosed, they were very young and
thus they may not have had the cognitive capacity to comprehend the impact of their
disease and what their future holds. But for the parents this is often a devastating time
and the clinical experience is that parents seem to be more affected, emotionally, than the
child himself because parents are able to envision their child’s future and how DMD will
impact it. It should also be noted that any interpretation of results must be done with
caution as the samples sizes are small. It might also be worthwhile, in the future, to
compare the HRQOL of parents whose boys were recently diagnosed to that of parents
whose boys who had been diagnosed for longer.
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5.1.6

Compare QOL and HRQOL of boys who lost ambulation
recently to those who lost ambulation longer ago
(Objective 6).

Loss of ambulation is considered a major transition point in the course of DMD. In the
non-ambulatory group, there were no statistically significant differences between boys
who lost ambulation within the last year and boys who have been non-ambulant for
longer than one year. However, the lack of significance could be due to small sample
sizes, as there were only 3 boys who lost ambulation within the past year. The boys who
lost ambulation over one year ago had much better HRQOL than boys who lost
ambulation more recently, even though the differences were not significant. It seems that
loss of ambulation is a particularly distressing event for the boys with DMD and their
parents. This was found to be the case by Bray et al. (2011) who reported that parents of
boys with DMD reported that their son’s transition to wheelchair had a very negative
emotional impact, and that their emotional coping was disrupted at time of loss of
ambulation. It is also possible that as time passes, there is some adjustment in the
HRQOL after the first year as the child stays in the long period of non-ambulation
plateau.

5.2 Implications
This study examined QOL and HRQOL in a sample of boys with DMD across Canada. It
demonstrated the feasibility and some of the challenges of using a nation-wide registry,
the CNDR, and mail-out questionnaires to conduct research studies. A national, clinic
based registry is a valuable research tool for studies of this nature. The ability to engage a
broad representative sample of patients from different clinics and regions is reassuring for
generalizing the results to the larger DMD population. Further, the ability to use accurate
data collected in the clinic confers more confidence in study results than patient driven
web-based registries available in other countries. Of particular importance to the
generalizability of patient reported outcomes such as QOL and HRQOL, is the ability to
compare respondents to non-respondents and determine if any significant differences
exist. A registry based study can provide this valuable information.
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This study replicated previous findings that HRQOL in boys with DMD are poorer than
that of healthy children, from both children’s and parents’ perspectives. Also in line with
other studies, we found that the social aspect of HRQOL in boys with DMD are affected
more than emotional and school aspects. Given this knowledge, efforts can be made to
enhance the social HRQOL of boys with DMD. For example, these boys may participate
in social skills training program to improve their abilities to interact with others.
Furthermore, teachers and education assistants can develop programs and scenarios that
encourage more seamless participation of boys with DMD alongside their typically
developing classmates. Finally, school-based education programs may also be
implemented to reduce stigma, improve knowledge and attitudes toward boys with DMD.
Such programs have found success with epilepsy (Martiniuk et al., 2007).
To our knowledge, this is the first study that explores the relationship between QOL and
HRQOL in the DMD population, and one of very few studies that have addressed these
concepts in the child health realm. The finding that QOL and HRQOL are distinct but
related concepts corroborates the findings of Feldman et al. (2000). This finding
emphasizes the need to recognize QOL as a more holistic representation of the child’s
subjective experiences. Such recognition can help clinicians to more effectively guide
families of boys with DMD in making disease management decisions that will have the
most beneficial impact on the lives of these boys, not just their health. In addition, this
finding highlights the importance of continued investigation into the relationship between
QOL and HRQOL. For example, a qualitative study may be carried out where boys with
DMD and their parents are asked how their ideas of QOL and HRQOL differ.
Information from this type of study could drive further cross-sectional and longitudinal
studies that include a more comprehensive dataset to better understand the contributions
of various factors to QOL and HRQOL.
This study identified fatigue as a potentially modifiable factor associated with a number
of HRQOL outcomes, which was an unexplored concept in DMD. The formal assessment
of fatigue has not been a focus of standard clinical care for children with DMD either,
and our conclusions suggest that it warrants much more attention from clinicians.
Modifying school and home schedule to ensure adequate rest, and improving sleep
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hygiene could also lead to reduction of fatigue. The higher level of fatigue in boys who
use wheelchair intermittent compared to those use wheelchairs full-time suggest that
earlier initiation of full-time wheelchair use could reduce fatigue, and if families and
clinicians are more aware of the impact on HRQOL then this may become a more
palatable intervention. Other implications for clinicians arise from this study, placing
increasing importance on understanding factors that contribute to fatigue. For example
sleep apnea is a commonly reported problem in children with DMD (Polat et al., 2012)
and contributes to daytime sleepiness and fatigue, perhaps earlier monitoring of sleep
quality can be initiated to reduce fatigue.
Even though this was a cross-sectional study, it supported the paradigm that loss of
ambulation is an extremely stressful event. Perhaps in addition of providing the boys with
DMD with wheelchair support, emotional support, such as referral to a counselor could
also be provided. Anticipatory guidance about wheelchair is likely lacking currently in
the clinics as so much of the focus is on preventing loss of ambulation, and real
discussion and planning about wheelchair use is often neglected. The knowledge that
HRQOL of boys who lost ambulation seem to be better in those who have been nonambulant for longer period of time, and that advancing age is not necessarily associated
with a progressive decline of HRQOL, could also offer hope to children and parents who
do not recognize that their HRQOL does not precipitously fall over time.
The Food and Drug Administration has mandated that patient-reported outcomes such as
QOL and HRQOL be included as endpoints of clinical trials. A number of promising
therapies for DMD are in various stages of clinical trials. In order to be able to interpret
these forthcoming results, minimally clinically important differences (MCID) need to be
established to understand the magnitude of change that is meaningful to patients. MCIDs
of QOL and HRQOL measures are important on their own, and they also help to establish
clinical meaningfulness of other commonly used endpoints such as 6-Minute Walk Test
through associating changes in these endpoints to changes in HRQOL outcomes. Our
study provided a profile of HRQOL at different stages and set the foundation for
longitudinal studies in order to establish MCIDs.
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Our identification of fatigue as a potential determinant of HRQOL suggests that perhaps
fatigue could be measured alongside HRQOL in future clinical trials. Inclusion of fatigue
measures would help us determine whether the treatment in question has an effect on
fatigue as well as HRQOL. Longitudinal study involving both fatigue and HRQOL
measures would also establish magnitude of change in fatigue that corresponds with a
meaningful change in HRQOL. Furthermore, since fatigue appears to be such an
important factor associated with HRQOL in boys with DMD, and fatigue is a
multidimensional measure, future research should explore specific aspects of fatigue that
contribute most to HRQOL. Doing so would enable clinicians to target a specific aspect
of fatigue (e.g. sleep/rest fatigue) that might have the biggest impact on improving
HRQOL in boys with DMD. Finally, the relationship between fatigue and other clinical
endpoints such as 6-Minute Walk Test and strength measures could be established in
future studies to compare sensitivity of clinical endpoints to changes in disease severity
Our study showed support for the notion that QOL and HRQOL are distinct but related
concepts and we believe this finding could have implications for clinical trial outcomes.
There is a theory that QOL tend to stay more stable than HRQOL over time (Cummins,
1998), as people tend to maintain a state of homeostasis in their lives. Thus, in clinical
trials, if we have both QOL and HRQOL measures, we would expect HRQOL may
change more in response to the treatment. Having a measure of QOL could serve as a
reference point, and help us better interpret changes in HRQOL.

5.3 Strengths and Limitations
There are several strengths of our study. This study offered one of the most
comprehensive examinations of QOL and HRQOL in the pediatric DMD population to
date. It was one of the first that used a national registry to recruit patients and thus is
made up of a more representative sample than studies that recruited their participants
from a single clinic. This study used a variety of measures that ranged from general to
disease-specific and included both child self-report and parent proxy-report, to capture
the most complete perspective possible. This study is the first to examine child and
family factors associated with HRQOL via multivariable regressions. We identified a
potentially modifiable clinical factor, fatigue that could lead to improvement of HRQOL
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in this population. Finally, this was the first study that explored the relationship between
QOL and HRQOL, providing empirical evidence for the distinction between these two
concepts.
This study also had a number of limitations. The cross-sectional nature of the study did
not allow for causal relationships to be established. Also, the QoML measure has not
been validated in the DMD population, nor has it been used, to our knowledge, in young
children. A study found that only 42% of kindergarten aged children (5.0-6.8 years of
age) were able to complete VAS scales satisfactorily on their own (Shields et al., 2003).
In the young children group in our sample, 50% (N=13) of the QoML measures were not
filled (returned blank). Of the young children who did complete the QoML measure, the
majority had checked the box beside ‘this form with filled out by my parent’.
Presumably, for these children, their answers were physically marked on the VAS by
their parents. This brings forth another limitation, which is that due to the mail-out nature
of our study, we cannot be sure of the extent to which parents ‘helped’ their boys
completes their questionnaire. We had provided instructions for children and parents to
complete their questionnaires independently, and if the child does require help with
reading comprehension, that the parent does not influence their child’s answers.
However, it is still possible that some parents had some influence over their child’s
responses. One way of examining this potential issue is to compare the concordance
between children and parents in our sample to studies where one can be sure children and
parents completed HRQOL assessments independently. For example, some studies had
their participants complete the questionnaires in clinics under the supervision of research
assistants (Davis et al., 2010; Uzark et al., 2012). If the concordance in our sample is
significantly higher than those of other studies, it might suggest that parents had ‘helped’
their children complete their questionnaires. Another potential limitation is the accuracy
of the CNDR information. Registry updates are reliant upon individual clinics, and
clinical information is supposed to be updated each time a patient visits clinic. Due to
limited resources at some sites, not all patients have the most updated information. Thus,
some of the clinical characteristics in our study, despite our best efforts, were out of date
(e.g. FVC was more than a year old). However, the majority of the patients did have up-
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to-date information in the registry, particularly with regards to major disease milestones
such as transition to intermittent and full-time wheelchair use.
Lastly, our response rate of 56% is not ideal, generating a concern regarding the
generalizability of our results. This concern is somewhat alleviated by the use of a
registry to recruit participants, which allowed for their comparison to non-participants on
a number of characteristics such as age and ambulation status. There were no statistically
significant differences between the two groups in any of these characteristics, suggesting
that our respondents are fairly similar to those who did not respond. However, as the nonrespondents were slightly older and more likely to have lost ambulation, it is possible that
the non-respondents are at a more severe stage of the disease than boys who did respond.
Therefore, it is possible that the QOL and HRQOL are somewhat overestimated in our
sample, especially in the physical domain.
A possible reason for our response rate could be related to our recruitment method. Per
policies of the CNDR, we, as the study investigators, could not have direct contact with
families who did not respond to our questionnaires. This lack of direct contact may have
limited our response rate as it has been shown that contacting potential participants
before sending the questionnaire and contacting non-respondents directly increased final
response rates (Edwards, 2002).

5.4 Conclusions and Future Work
QOL and HRQOL of boys with DMD as judged by self-report and parent-report, are
worse than the healthy population, and children with other types of chronic illnesses.
Domains related to physical function were affected more than domains related to
psychological and social functioning. It appears that QOL and HRQOL are related
constructs, but there are factors outside of HRQOL that contribute to the QOL of boys
with DMD. Further research is needed is to elucidate these factors. Fatigue has emerged
as a clinically amendable factor associated with HRQOL and warrants further attention
from clinicians and researchers. Lastly, it appears that loss of ambulation is particularly
difficult event for the boys and their parents, but there is evidence that HRQOL
potentially improves over time.
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We are currently in the process of extending our cross-sectional project into a two-year
longitudinal project and have already begun the process of collecting data for the second
time point. We will be able to track temporal changes in QOL and HRQOL in our sample
of boys with DMD, and be able to explore the relationship between QOL and HRQOL
over time. Finally, we will be able to establish more causal relationships between
potential determinants of HRQOL and HRQOL outcomes.
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